CPSR superpanel (v3.0)
----------------------

We have aggregated data from multiple sources to compile an exploratory
track of **n = 433** genes with associations to cancer
predisposition/cancer syndromes:

-  *TCGA_PANCAN_18* - TCGCA Pancancer germline study - `Huang et al,
   Cell, 2018 <https://www.ncbi.nlm.nih.gov/pubmed/29625052>`__
-  *CGC_94* - Curated list - `Cancer Gene Census
   (COSMIC) <https://cancer.sanger.ac.uk/census>`__ - version 94
-  *NCGC* - Expert-curated list from `Norwegian Cancer Genomics
   Consortium <http://cancergenomics.no>`__
-  *PANEL_APP* - knowledge base of virtual gene panels related to human
   disorders - all unique genes from 42 panels linked to inherited
   cancers and cancer susceptibility
-  *OTHER* - Other potential cancer-relevant genes, as contributed by
   the CPSR user community

Data with respect to mechanisms of inheritance (MoI - autosomal
recessive (AR) vs.Â autosomal dominant (AD) etc.) and whether mechanisms
of disease are associated with loss-of-function (LoF) or
gain-of-function (GoF) were primarily retrieved from `Maxwell et al., Am
J Hum Genet, 2016 <https://www.ncbi.nlm.nih.gov/pubmed/27153395>`__, and
`Genomics England PanelApp <https://panelapp.genomicsengland.co.uk/>`__

We want to make it explicit that this lis by no means regarded as an
international consensus, but should rather be subject to continuous
update by the international community that carry expertise on genetic
risk factors for cancer.

Do you miss other genes of relevance for cancer predisposition/inherited
tumor syndromes? Please forward a list of gene identifiers, preferably
also with mode of inheritance and literature support to sigven AT
ifi.uio.no, so we can include them in Panel 0.

`Download the complete set of CPSR superpanel genes, grch37/grch38
versions (xlsx) <cpsr_superpanel_0.6.2.xlsx>`__

+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| n | gene_link   | e | e | m | m | gene_name     | s     | ph                    |
| o |             | n | n | o | o |               | ource | enotype_syndrome_term |
|   |             | t | s | i | d |               |       |                       |
|   |             | r | e |   |   |               |       |                       |
|   |             | e | m |   |   |               |       |                       |
|   |             | z | b |   |   |               |       |                       |
|   |             | g | l |   |   |               |       |                       |
|   |             | e | _ |   |   |               |       |                       |
|   |             | n | g |   |   |               |       |                       |
|   |             | e | e |   |   |               |       |                       |
|   |             |   | n |   |   |               |       |                       |
|   |             |   | e |   |   |               |       |                       |
|   |             |   | _ |   |   |               |       |                       |
|   |             |   | i |   |   |               |       |                       |
|   |             |   | d |   |   |               |       |                       |
+===+=============+===+===+===+===+===============+=======+=======================+
| 1 | ABCB11      | 8 | E | A | L | ATP binding   | T     | Crigler-Najjar        |
|   |             | 6 | N | R | o | cassette      | CGA_P | syndrome, type II     |
|   |             | 4 | S |   | F | subfamily B   | ANCAN |                       |
|   |             | 7 | G |   |   | member 11     | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ABL1        | 2 | E | N | N | ABL           | OTHER | NA                    |
|   |             | 5 | N | A | A | p             |       |                       |
|   |             |   | S |   |   | roto-oncogene |       |                       |
|   |             |   | G |   |   | 1,            |       |                       |
|   |             |   | 0 |   |   | non-receptor  |       |                       |
|   |             |   | 0 |   |   | tyrosine      |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | ABL2        | 2 | E | N | N | ABL           | OTHER | NA                    |
|   |             | 7 | N | A | A | p             |       |                       |
|   |             |   | S |   |   | roto-oncogene |       |                       |
|   |             |   | G |   |   | 2,            |       |                       |
|   |             |   | 0 |   |   | non-receptor  |       |                       |
|   |             |   | 0 |   |   | tyrosine      |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | ABRAXAS1    | 8 | E | N | N | abraxas 1,    | NCGC  | NA                    |
|   |             | 4 | N | A | A | BRCA1 A       |       |                       |
|   |             | 1 | S |   |   | complex       |       |                       |
|   |             | 4 | G |   |   | subunit       |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | ACD         | 6 | E | A | N | ACD shelterin | NCGC  | NA                    |
|   |             | 5 | N | D | A | complex       | ,PANE |                       |
|   |             | 0 | S | / |   | subunit and   | L_APP |                       |
|   |             | 5 | G | A |   | telomerase    |       |                       |
|   |             | 7 | 0 | R |   | recruitment   |       |                       |
|   |             |   | 0 |   |   | factor        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | ACTRT1      | 1 | E | A | N | actin related | PANE  | NA                    |
|   |             | 3 | N | D | A | protein T1    | L_APP |                       |
|   |             | 9 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | ADM         | 1 | E | N | N | a             | PANE  | NA                    |
|   |             | 3 | N | A | A | drenomedullin | L_APP |                       |
|   |             | 3 | S |   |   |               |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | AIP         | 9 | E | A | L | aryl          | NCGC  | NA                    |
|   |             | 0 | N | D | o | hydrocarbon   | ,PANE |                       |
|   |             | 4 | S |   | F | receptor      | L_APP |                       |
|   |             | 9 | G |   |   | interacting   |       |                       |
|   |             |   | 0 |   |   | protein       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | AKT1        | 2 | E | A | G | AKT           | NCGC  | NA                    |
|   |             | 0 | N | D | o | ser           | ,PANE |                       |
|   |             | 7 | S |   | F | ine/threonine | L_APP |                       |
|   |             |   | G |   |   | kinase 1      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ALK         | 2 | E | A | G | ALK receptor  | CGC   | Neuroblastoma         |
| 0 |             | 3 | N | D | o | tyrosine      | _94,N |                       |
|   |             | 8 | S |   | F | kinase        | CGC,P |                       |
|   |             |   | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | AMER1       | 1 | E | N | N | APC membrane  | OTHER | NA                    |
| 1 |             | 3 | N | A | A | recruitment   |       |                       |
|   |             | 9 | S |   |   | protein 1     |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ANKRD26     | 2 | E | A | N | ankyrin       | PANE  | NA                    |
| 2 |             | 2 | N | D | A | repeat domain | L_APP |                       |
|   |             | 8 | S |   |   | 26            |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | APC         | 3 | E | A | L | APC regulator | ACM   | Familial multiple     |
| 3 |             | 2 | N | D | o | of WNT        | G_SF3 | polyposis syndrome;   |
|   |             | 4 | S | / | F | signaling     | 0,CGC | Familial adenomatous  |
|   |             |   | G | A |   | pathway       | _94,N | polyposis 1           |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | APOBEC3B    | 9 | E | A | N | a             | C     | NA                    |
| 4 |             | 5 | N | R | A | polipoprotein | GC_94 |                       |
|   |             | 8 | S |   |   | B mRNA        |       |                       |
|   |             | 2 | G |   |   | editing       |       |                       |
|   |             |   | 0 |   |   | enzyme        |       |                       |
|   |             |   | 0 |   |   | catalytic     |       |                       |
|   |             |   | 0 |   |   | subunit 3B    |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | AR          | 3 | E | A | N | androgen      | C     | NA                    |
| 5 |             | 6 | N | D | A | receptor      | GC_94 |                       |
|   |             | 7 | S |   |   |               | ,PANE |                       |
|   |             |   | G |   |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ARHGEF12    | 2 | E | N | N | Rho guanine   | OTHER | NA                    |
| 6 |             | 3 | N | A | A | nucleotide    |       |                       |
|   |             | 3 | S |   |   | exchange      |       |                       |
|   |             | 6 | G |   |   | factor 12     |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ARID1A      | 8 | E | A | N | AT-rich       | OTHER | NA                    |
| 7 |             | 2 | N | D | A | interaction   |       |                       |
|   |             | 8 | S |   |   | domain 1A     |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ARID2       | 1 | E | A | N | AT-rich       | OTHER | NA                    |
| 8 |             | 9 | N | D | A | interaction   |       |                       |
|   |             | 6 | S |   |   | domain 2      |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ARID5B      | 8 | E | N | N | AT-rich       | OTHER | NA                    |
| 9 |             | 4 | N | A | A | interaction   |       |                       |
|   |             | 1 | S |   |   | domain 5B     |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ARMC5       | 7 | E | A | N | armadillo     | OTHER | NA                    |
| 0 |             | 9 | N | D | A | repeat        |       |                       |
|   |             | 7 | S |   |   | containing 5  |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ASXL1       | 1 | E | N | N | ASXL          | OTHER | NA                    |
| 1 |             | 7 | N | A | A | tr            |       |                       |
|   |             | 1 | S |   |   | anscriptional |       |                       |
|   |             | 0 | G |   |   | regulator 1   |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ATM         | 4 | E | A | L | ATM           | CGC   | Ataxia-telangiectasia |
| 2 |             | 7 | N | D | o | ser           | _94,N | syndrome              |
|   |             | 2 | S | / | F | ine/threonine | CGC,P |                       |
|   |             |   | G | A |   | kinase        | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ATR         | 5 | E | A | L | ATR           | CGC   | Seckel syndrome;      |
| 3 |             | 4 | N | D | o | ser           | _94,P | Cutaneous             |
|   |             | 5 | S |   | F | ine/threonine | ANEL_ | telangiectasia and    |
|   |             |   | G |   |   | kinase        | APP,T | cancer syndrome,      |
|   |             |   | 0 |   |   |               | CGA_P | familial              |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | ATRX        | 5 | E | N | N | ATRX          | OTHER | NA                    |
| 4 |             | 4 | N | A | A | chromatin     |       |                       |
|   |             | 6 | S |   |   | remodeler     |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | AXIN1       | 8 | E | N | N | axin 1        | NCGC  | NA                    |
| 5 |             | 3 | N | A | A |               |       |                       |
|   |             | 1 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | AXIN2       | 8 | E | A | L | axin 2        | CGC   | O                     |
| 6 |             | 3 | N | D | o |               | _94,N | ligodontia-colorectal |
|   |             | 1 | S | / | F |               | CGC,T | cancer syndrome       |
|   |             | 3 | G | A |   |               | CGA_P |                       |
|   |             |   | 0 | R |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | BAP1        | 8 | E | A | L | BRCA1         | CGC   | Tumor susceptibility  |
| 7 |             | 3 | N | D | o | associated    | _94,N | linked to germline    |
|   |             | 1 | S | / | F | protein 1     | CGC,P | BAP1 mutations; BAP1  |
|   |             | 4 | G | A |   |               | ANEL_ | Cancer Syndrome       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | BARD1       | 5 | E | A | L | BRCA1         | C     | NA                    |
| 8 |             | 8 | N | R | o | associated    | GC_94 |                       |
|   |             | 0 | S |   | F | RING domain 1 | ,NCGC |                       |
|   |             |   | G |   |   |               | ,PANE |                       |
|   |             |   | 0 |   |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | BCL10       | 8 | E | A | N | BCL10 immune  | OTHER | NA                    |
| 9 |             | 9 | N | R | A | signaling     |       |                       |
|   |             | 1 | S |   |   | adaptor       |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BCR         | 6 | E | N | N | BCR activator | OTHER | NA                    |
| 0 |             | 1 | N | A | A | of RhoGEF and |       |                       |
|   |             | 3 | S |   |   | GTPase        |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BLM         | 6 | E | A | L | BLM RecQ like | CGC   | Bloom syndrome        |
| 1 |             | 4 | N | R | o | helicase      | _94,N |                       |
|   |             | 1 | S |   | F |               | CGC,P |                       |
|   |             |   | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BMPR1A      | 6 | E | A | L | bone          | ACM   | Juvenile polyposis    |
| 2 |             | 5 | N | D | o | morphogenetic | G_SF3 | syndrome              |
|   |             | 7 | S | / | F | protein       | 0,CGC |                       |
|   |             |   | G | A |   | receptor type | _94,N |                       |
|   |             |   | 0 | R |   | 1A            | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BRAF        | 6 | E | A | N | B-Raf         | P     | Noonan syndrome 7;    |
| 3 |             | 7 | N | D | A | pr            | ANEL_ | LEOPARD syndrome 3    |
|   |             | 3 | S |   |   | oto-oncogene, | APP,T |                       |
|   |             |   | G |   |   | ser           | CGA_P |                       |
|   |             |   | 0 |   |   | ine/threonine | ANCAN |                       |
|   |             |   | 0 |   |   | kinase        | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BRCA1       | 6 | E | A | L | BRCA1 DNA     | ACM   | Hereditary breast and |
| 4 |             | 7 | N | D | o | repair        | G_SF3 | ovarian cancer        |
|   |             | 2 | S | / | F | associated    | 0,CGC | syndrome              |
|   |             |   | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BRCA2       | 6 | E | A | L | BRCA2 DNA     | ACM   | Hereditary breast and |
| 5 |             | 7 | N | D | o | repair        | G_SF3 | ovarian cancer        |
|   |             | 5 | S | / | F | associated    | 0,CGC | syndrome; Fanconi     |
|   |             |   | G | A |   |               | _94,N | anemia,               |
|   |             |   | 0 | R |   |               | CGC,P | complementation group |
|   |             |   | 0 |   |   |               | ANEL_ | D1                    |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BRIP1       | 8 | E | A | L | BRCA1         | CGC   | Fanconi anemia,       |
| 6 |             | 3 | N | D | o | interacting   | _94,N | complementation group |
|   |             | 9 | S | / | F | helicase 1    | CGC,P | J                     |
|   |             | 9 | G | A |   |               | ANEL_ |                       |
|   |             | 0 | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BTK         | 6 | E | X | N | Bruton        | OTHER | NA                    |
| 7 |             | 9 | N | L | A | tyrosine      |       |                       |
|   |             | 5 | S | R |   | kinase        |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BUB1        | 6 | E | N | N | BUB1 mitotic  | NCGC  | NA                    |
| 8 |             | 9 | N | A | A | checkpoint    |       |                       |
|   |             | 9 | S |   |   | ser           |       |                       |
|   |             |   | G |   |   | ine/threonine |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | BUB1B       | 7 | E | A | L | BUB1 mitotic  | CGC   | Mosaic variegated     |
| 9 |             | 0 | N | R | o | checkpoint    | _94,N | aneuploidy syndrome 1 |
|   |             | 1 | S |   | F | ser           | CGC,P |                       |
|   |             |   | G |   |   | ine/threonine | ANEL_ |                       |
|   |             |   | 0 |   |   | kinase B      | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | BUB3        | 9 | E | N | N | BUB3 mitotic  | OTHER | NA                    |
| 0 |             | 1 | N | A | A | checkpoint    |       |                       |
|   |             | 8 | S |   |   | protein       |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CAMTA1      | 2 | E | N | N | calmodulin    | OTHER | NA                    |
| 1 |             | 3 | N | A | A | binding       |       |                       |
|   |             | 2 | S |   |   | transcription |       |                       |
|   |             | 6 | G |   |   | activator 1   |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CASP8       | 8 | E | A | N | caspase 8     | OTHER | NA                    |
| 2 |             | 4 | N | D | A |               |       |                       |
|   |             | 1 | S |   |   |               |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CASR        | 8 | E | N | N | calcium       | NCGC  | NA                    |
| 3 |             | 4 | N | A | A | sensing       | ,PANE |                       |
|   |             | 6 | S |   |   | receptor      | L_APP |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CBFA2T3     | 8 | E | N | N | CBFA2/RUNX1   | OTHER | NA                    |
| 4 |             | 6 | N | A | A | partner       |       |                       |
|   |             | 3 | S |   |   | tr            |       |                       |
|   |             |   | G |   |   | anscriptional |       |                       |
|   |             |   | 0 |   |   | co-repressor  |       |                       |
|   |             |   | 0 |   |   | 3             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CBL         | 8 | E | A | L | Cbl           | P     | Noonan syndrome       |
| 5 |             | 6 | N | D | o | p             | ANEL_ |                       |
|   |             | 7 | S |   | F | roto-oncogene | APP,T |                       |
|   |             |   | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CDC73       | 7 | E | A | L | cell division | CGC   | Hyperparathyroidism 2 |
| 6 |             | 9 | N | D | o | cycle 73      | _94,N |                       |
|   |             | 5 | S | / | F |               | CGC,P |                       |
|   |             | 7 | G | A |   |               | ANEL_ |                       |
|   |             | 7 | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CDH1        | 9 | E | A | L | cadherin 1    | CGC   | Hereditary diffuse    |
| 7 |             | 9 | N | D | o |               | _94,N | gastric cancer        |
|   |             | 9 | S | / | F |               | CGC,P |                       |
|   |             |   | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CDH10       | 1 | E | N | N | cadherin 10   | C     | NA                    |
| 8 |             | 0 | N | A | A |               | GC_94 |                       |
|   |             | 0 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | CDH11       | 1 | E | N | N | cadherin 11   | OTHER | NA                    |
| 9 |             | 0 | N | A | A |               |       |                       |
|   |             | 0 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDK4        | 1 | E | A | G | cyclin        | CGC   | Hereditary melanoma;  |
| 0 |             | 0 | N | D | o | dependent     | _94,N | Cutaneous malignant   |
|   |             | 1 | S |   | F | kinase 4      | CGC,P | melanoma 3            |
|   |             | 9 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN1A      | 1 | E | N | N | cyclin        | OTHER | NA                    |
| 1 |             | 0 | N | A | A | dependent     |       |                       |
|   |             | 2 | S |   |   | kinase        |       |                       |
|   |             | 6 | G |   |   | inhibitor 1A  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN1B      | 1 | E | A | L | cyclin        | CGC   | Multiple endocrine    |
| 2 |             | 0 | N | D | o | dependent     | _94,N | neoplasia, type 4     |
|   |             | 2 | S | / | F | kinase        | CGC,P |                       |
|   |             | 7 | G | A |   | inhibitor 1B  | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN1C      | 1 | E | A | L | cyclin        | N     | Beckwith-Wiedemann    |
| 3 |             | 0 | N | D | o | dependent     | CGC,P | syndrome              |
|   |             | 2 | S |   | F | kinase        | ANEL_ |                       |
|   |             | 8 | G |   |   | inhibitor 1C  | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN2A      | 1 | E | A | L | cyclin        | CGC   | Hereditary melanoma   |
| 4 |             | 0 | N | D | o | dependent     | _94,N |                       |
|   |             | 2 | S | / | F | kinase        | CGC,P |                       |
|   |             | 9 | G | A |   | inhibitor 2A  | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN2B      | 1 | E | A | N | cyclin        | PANE  | NA                    |
| 5 |             | 0 | N | D | A | dependent     | L_APP |                       |
|   |             | 3 | S |   |   | kinase        |       |                       |
|   |             | 0 | G |   |   | inhibitor 2B  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CDKN2C      | 1 | E | N | N | cyclin        | OTHER | NA                    |
| 6 |             | 0 | N | A | A | dependent     |       |                       |
|   |             | 3 | S |   |   | kinase        |       |                       |
|   |             | 1 | G |   |   | inhibitor 2C  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CEBPA       | 1 | E | A | L | CCAAT         | N     | Acute myeloid         |
| 7 |             | 0 | N | D | o | enhancer      | CGC,P | leukemia              |
|   |             | 5 | S |   | F | binding       | ANEL_ |                       |
|   |             | 0 | G |   |   | protein alpha | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CEBPE       | 1 | E | A | N | CCAAT         | OTHER | NA                    |
| 8 |             | 0 | N | R | A | enhancer      |       |                       |
|   |             | 5 | S |   |   | binding       |       |                       |
|   |             | 3 | G |   |   | protein       |       |                       |
|   |             |   | 0 |   |   | epsilon       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 5 | CENPJ       | 5 | E | N | N | centromere    | OTHER | NA                    |
| 9 |             | 5 | N | A | A | protein J     |       |                       |
|   |             | 8 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CEP57       | 9 | E | A | L | centrosomal   | NCGC  | NA                    |
| 0 |             | 7 | N | R | o | protein 57    |       |                       |
|   |             | 0 | S |   | F |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CHEK1       | 1 | E | N | N | checkpoint    | NCGC  | NA                    |
| 1 |             | 1 | N | A | A | kinase 1      |       |                       |
|   |             | 1 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CHEK2       | 1 | E | A | L | checkpoint    | CGC   | Familial cancer of    |
| 2 |             | 1 | N | D | o | kinase 2      | _94,N | breast                |
|   |             | 2 | S | / | F |               | CGC,P |                       |
|   |             | 0 | G | A |   |               | ANEL_ |                       |
|   |             | 0 | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CIB1        | 1 | E | A | N | calcium and   | PANE  | NA                    |
| 3 |             | 0 | N | R | A | integrin      | L_APP |                       |
|   |             | 5 | S |   |   | binding 1     |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | COL7A1      | 1 | E | A | L | collagen type | T     | Epidermolysis bullosa |
| 4 |             | 2 | N | D | o | VII alpha 1   | CGA_P |                       |
|   |             | 9 | S | / | F | chain         | ANCAN |                       |
|   |             | 4 | G | A |   |               | _2018 |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CREBBP      | 1 | E | A | N | CREB binding  | PANE  | NA                    |
| 5 |             | 3 | N | D | A | protein       | L_APP |                       |
|   |             | 8 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CSF3R       | 1 | E | A | N | colony        | PANE  | NA                    |
| 6 |             | 4 | N | D | A | stimulating   | L_APP |                       |
|   |             | 4 | S |   |   | factor 3      |       |                       |
|   |             | 1 | G |   |   | receptor      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CTC1        | 8 | E | A | N | CST telomere  | PANE  | NA                    |
| 7 |             | 0 | N | R | A | replication   | L_APP |                       |
|   |             | 1 | S |   |   | complex       |       |                       |
|   |             | 6 | G |   |   | component 1   |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CTNNA1      | 1 | E | A | L | catenin alpha | NCGC, | NA                    |
| 8 |             | 4 | N | D | o | 1             | OTHER |                       |
|   |             | 9 | S |   | F |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 6 | CTNNB1      | 1 | E | A | N | catenin beta  | NCGC  | NA                    |
| 9 |             | 4 | N | D | A | 1             | ,PANE |                       |
|   |             | 9 | S |   |   |               | L_APP |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | CTR9        | 9 | E | A | N | CTR9 homolog, | P     | NA                    |
| 0 |             | 6 | N | D | A | Paf1/RNA      | ANEL_ |                       |
|   |             | 4 | S |   |   | polymerase II | APP,T |                       |
|   |             | 6 | G |   |   | complex       | CGA_P |                       |
|   |             |   | 0 |   |   | component     | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | CTRC        | 1 | E | N | N | chymotrypsin  | NCGC  | NA                    |
| 1 |             | 1 | N | A | A | C             |       |                       |
|   |             | 3 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | CXCR4       | 7 | E | A | N | C-X-C motif   | C     | NA                    |
| 2 |             | 8 | N | D | A | chemokine     | GC_94 |                       |
|   |             | 5 | S |   |   | receptor 4    |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | CYLD        | 1 | E | A | L | CYLD lysine   | CGC   | Brooke-Spiegler       |
| 3 |             | 5 | N | D | o | 63            | _94,N | syndrome              |
|   |             | 4 | S | / | F | d             | CGC,P |                       |
|   |             | 0 | G | A |   | eubiquitinase | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DDB2        | 1 | E | A | L | damage        | CGC   | Xeroderma             |
| 4 |             | 6 | N | D | o | specific DNA  | _94,N | pigmentosum, group E  |
|   |             | 4 | S | / | F | binding       | CGC,P |                       |
|   |             | 3 | G | A |   | protein 2     | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DDX11       | 1 | E | A | N | DEAD/H-box    | OTHER | NA                    |
| 5 |             | 6 | N | R | A | helicase 11   |       |                       |
|   |             | 6 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DDX41       | 5 | E | A | N | DEAD-box      | PANE  | NA                    |
| 6 |             | 1 | N | D | A | helicase 41   | L_APP |                       |
|   |             | 4 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DGCR8       | 5 | E | A | N | DGCR8         | PANE  | NA                    |
| 7 |             | 4 | N | D | A | m             | L_APP |                       |
|   |             | 4 | S |   |   | icroprocessor |       |                       |
|   |             | 8 | G |   |   | complex       |       |                       |
|   |             | 7 | 0 |   |   | subunit       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DHCR7       | 1 | E | A | N | 7-dehyd       | OTHER | NA                    |
| 8 |             | 7 | N | R | A | rocholesterol |       |                       |
|   |             | 1 | S |   |   | reductase     |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 7 | DICER1      | 2 | E | A | L | dicer 1,      | CGC   | Pleuropulmonary       |
| 9 |             | 3 | N | D | o | ribonuclease  | _94,N | blastoma;             |
|   |             | 4 | S | / | F | III           | CGC,P | DICER1-related        |
|   |             | 0 | G | A |   |               | ANEL_ | pleuropulmonary       |
|   |             | 5 | 0 | R |   |               | APP,T | blastoma cancer       |
|   |             |   | 0 |   |   |               | CGA_P | predisposition        |
|   |             |   | 0 |   |   |               | ANCAN | syndrome              |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DIRAS3      | 9 | E | N | N | DIRAS family  | NCGC  | NA                    |
| 0 |             | 0 | N | A | A | GTPase 3      | ,PANE |                       |
|   |             | 7 | S |   |   |               | L_APP |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DIS3        | 2 | E | N | N | DIS3 homolog, | OTHER | NA                    |
| 1 |             | 2 | N | A | A | exosome       |       |                       |
|   |             | 8 | S |   |   | end           |       |                       |
|   |             | 9 | G |   |   | oribonuclease |       |                       |
|   |             | 4 | 0 |   |   | and 3â-5â     |       |                       |
|   |             |   | 0 |   |   | ex            |       |                       |
|   |             |   | 0 |   |   | oribonuclease |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DIS3L       | 1 | E | A | N | DIS3 like     | OTHER | NA                    |
| 2 |             | 1 | N | R | A | exosome 3â-5â |       |                       |
|   |             | 5 | S |   |   | ex            |       |                       |
|   |             | 7 | G |   |   | oribonuclease |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DIS3L2      | 1 | E | A | L | DIS3 like     | N     | Perlman syndrome      |
| 3 |             | 2 | N | R | o | 3â-5â         | CGC,P |                       |
|   |             | 9 | S |   | F | ex            | ANEL_ |                       |
|   |             | 5 | G |   |   | oribonuclease | APP,T |                       |
|   |             | 6 | 0 |   |   | 2             | CGA_P |                       |
|   |             | 3 | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DKC1        | 1 | E | N | L | dyskerin      | P     | Dyskeratosis          |
| 4 |             | 7 | N | A | o | pseudouridine | ANEL_ | congenita, X-linked   |
|   |             | 3 | S |   | F | synthase 1    | APP,T |                       |
|   |             | 6 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DNAJC21     | 1 | E | A | N | DnaJ heat     | PANE  | NA                    |
| 5 |             | 3 | N | R | A | shock protein | L_APP |                       |
|   |             | 4 | S |   |   | family        |       |                       |
|   |             | 2 | G |   |   | (Hsp40)       |       |                       |
|   |             | 1 | 0 |   |   | member C21    |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DOCK8       | 8 | E | A | L | dedicator of  | P     | Hyper-Immunoglobulin  |
| 6 |             | 1 | N | R | o | cytokinesis 8 | ANEL_ | E Syndrome, Autosomal |
|   |             | 7 | S |   | F |               | APP,T | Recessive             |
|   |             | 0 | G |   |   |               | CGA_P |                       |
|   |             | 4 | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DROSHA      | 2 | E | A | N | drosha        | T     | NA                    |
| 7 |             | 9 | N | D | A | ribonuclease  | CGA_P |                       |
|   |             | 1 | S |   |   | III           | ANCAN |                       |
|   |             | 0 | G |   |   |               | _2018 |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | DTX3L       | 1 | E | N | N | deltex E3     | NCGC  | NA                    |
| 8 |             | 5 | N | A | A | ubiquitin     |       |                       |
|   |             | 1 | S |   |   | ligase 3L     |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 8 | EGFR        | 1 | E | A | G | epidermal     | CGC   | NA                    |
| 9 |             | 9 | N | D | o | growth factor | _94,N |                       |
|   |             | 5 | S |   | F | receptor      | CGC,T |                       |
|   |             | 6 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ELAC2       | 6 | E | N | N | elaC          | PANE  | NA                    |
| 0 |             | 0 | N | A | A | ribonuclease  | L_APP |                       |
|   |             | 5 | S |   |   | Z 2           |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ELANE       | 1 | E | A | L | elastase,     | P     | Neutropenia, severe   |
| 1 |             | 9 | N | D | o | neutrophil    | ANEL_ | congenital 1,         |
|   |             | 9 | S |   | F | expressed     | APP,T | autosomal dominant    |
|   |             | 1 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ELP1        | 8 | E | A | N | elongator     | PANE  | NA                    |
| 2 |             | 5 | N | D | A | acet          | L_APP |                       |
|   |             | 1 | S |   |   | yltransferase |       |                       |
|   |             | 8 | G |   |   | complex       |       |                       |
|   |             |   | 0 |   |   | subunit 1     |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ENG         | 2 | E | A | N | endoglin      | ACMG  | Hereditary            |
| 3 |             | 0 | N | D | A |               | _SF30 | hemorrhagic           |
|   |             | 2 | S |   |   |               | ,NCGC | telangiectasia        |
|   |             | 2 | G |   |   |               | ,PANE |                       |
|   |             |   | 0 |   |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | EP300       | 2 | E | A | N | E1A binding   | OTHER | NA                    |
| 4 |             | 0 | N | D | A | protein p300  |       |                       |
|   |             | 3 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | EPAS1       | 2 | E | N | N | endothelial   | OTHER | NA                    |
| 5 |             | 0 | N | A | A | PAS domain    |       |                       |
|   |             | 3 | S |   |   | protein 1     |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | EPCAM       | 4 | E | A | L | epithelial    | N     | Hereditary            |
| 6 |             | 0 | N | D | o | cell adhesion | CGC,P | nonpolyposis          |
|   |             | 7 | S |   | F | molecule      | ANEL_ | colorectal cancer     |
|   |             | 2 | G |   |   |               | APP,T | type 8                |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ERBB2       | 2 | E | N | N | erb-b2        | OTHER | NA                    |
| 7 |             | 0 | N | A | A | receptor      |       |                       |
|   |             | 6 | S |   |   | tyrosine      |       |                       |
|   |             | 4 | G |   |   | kinase 2      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ERBB4       | 2 | E | A | N | erb-b2        | C     | NA                    |
| 8 |             | 0 | N | D | A | receptor      | GC_94 |                       |
|   |             | 6 | S |   |   | tyrosine      |       |                       |
|   |             | 6 | G |   |   | kinase 4      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 9 | ERCC1       | 2 | E | A | N | ERCC excision | N     | Cere                  |
| 9 |             | 0 | N | R | A | repair 1,     | CGC,P | brooculofacioskeletal |
|   |             | 6 | S |   |   | endonuclease  | ANEL_ | syndrome 4            |
|   |             | 7 | G |   |   | non-catalytic | APP,T |                       |
|   |             |   | 0 |   |   | subunit       | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERCC2       | 2 | E | A | L | ERCC excision | CGC   | Xeroderma             |
| 0 |             | 0 | N | R | o | repair 2,     | _94,N | pigmentosum, group D  |
| 0 |             | 6 | S |   | F | TFIIH core    | CGC,P |                       |
|   |             | 8 | G |   |   | complex       | ANEL_ |                       |
|   |             |   | 0 |   |   | helicase      | APP,T |                       |
|   |             |   | 0 |   |   | subunit       | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERCC3       | 2 | E | A | L | ERCC excision | CGC   | Xeroderma             |
| 0 |             | 0 | N | R | o | repair 3,     | _94,N | pigmentosum,          |
| 1 |             | 7 | S |   | F | TFIIH core    | CGC,P | complementation group |
|   |             | 1 | G |   |   | complex       | ANEL_ | b                     |
|   |             |   | 0 |   |   | helicase      | APP,T |                       |
|   |             |   | 0 |   |   | subunit       | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERCC4       | 2 | E | A | L | ERCC excision | CGC   | Xeroderma             |
| 0 |             | 0 | N | R | o | repair 4,     | _94,N | pigmentosum, group F; |
| 2 |             | 7 | S |   | F | endonuclease  | CGC,P | Fanconi anemia,       |
|   |             | 2 | G |   |   | catalytic     | ANEL_ | complementation group |
|   |             |   | 0 |   |   | subunit       | APP,T | Q                     |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERCC5       | 2 | E | A | L | ERCC excision | CGC   | Xeroderma             |
| 0 |             | 0 | N | R | o | repair 5,     | _94,N | pigmentosum, group G  |
| 3 |             | 7 | S |   | F | endonuclease  | CGC,P |                       |
|   |             | 3 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERCC6       | 2 | E | A | N | ERCC excision | OTHER | NA                    |
| 0 |             | 0 | N | D | A | repair 6,     |       |                       |
| 4 |             | 7 | S | / |   | chromatin     |       |                       |
|   |             | 4 | G | A |   | remodeling    |       |                       |
|   |             |   | 0 | R |   | factor        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ERG         | 2 | E | N | N | ETS           | OTHER | NA                    |
| 0 |             | 0 | N | A | A | transcription |       |                       |
| 5 |             | 7 | S |   |   | factor ERG    |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ESR1        | 2 | E | N | N | estrogen      | PANE  | NA                    |
| 0 |             | 0 | N | A | A | receptor 1    | L_APP |                       |
| 6 |             | 9 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ETV6        | 2 | E | A | N | ETS variant   | N     | Thrombocytopenia 5    |
| 0 |             | 1 | N | D | A | transcription | CGC,P |                       |
| 7 |             | 2 | S |   |   | factor 6      | ANEL_ |                       |
|   |             | 0 | G |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | EXO1        | 9 | E | N | N | exonuclease 1 | OTHER | NA                    |
| 0 |             | 1 | N | A | A |               |       |                       |
| 8 |             | 5 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | EXT1        | 2 | E | A | L | exostosin     | CGC   | Chondrosarcoma        |
| 0 |             | 1 | N | D | o | glycos        | _94,N |                       |
| 9 |             | 3 | S | / | F | yltransferase | CGC,P |                       |
|   |             | 1 | G | A |   | 1             | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | EXT2        | 2 | E | A | L | exostosin     | CGC   | Multiple exostoses    |
| 1 |             | 1 | N | D | o | glycos        | _94,N | type 2                |
| 0 |             | 3 | S | / | F | yltransferase | CGC,P |                       |
|   |             | 2 | G | A |   | 2             | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | EZH2        | 2 | E | A | L | enhancer of   | NCGC  | NA                    |
| 1 |             | 1 | N | D | o | zeste 2       | ,PANE |                       |
| 1 |             | 4 | S |   | F | polycomb      | L_APP |                       |
|   |             | 6 | G |   |   | repressive    |       |                       |
|   |             |   | 0 |   |   | complex 2     |       |                       |
|   |             |   | 0 |   |   | subunit       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FAH         | 2 | E | A | L | fumary        | T     | NA                    |
| 1 |             | 1 | N | R | o | lacetoacetate | CGA_P |                       |
| 2 |             | 8 | S |   | F | hydrolase     | ANCAN |                       |
|   |             | 4 | G |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FAN1        | 2 | E | N | N | FANCD2 and    | OTHER | NA                    |
| 1 |             | 2 | N | A | A | FANCI         |       |                       |
| 3 |             | 9 | S |   |   | associated    |       |                       |
|   |             | 0 | G |   |   | nuclease 1    |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCA       | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 1 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 4 |             | 7 | S |   | F | mplementation | CGC,P | A                     |
|   |             | 5 | G |   |   | group A       | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCB       | 2 | E | N | L | FA            | NCGC  | NA                    |
| 1 |             | 1 | N | A | o | co            | ,PANE |                       |
| 5 |             | 8 | S |   | F | mplementation | L_APP |                       |
|   |             | 7 | G |   |   | group B       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCC       | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 1 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 6 |             | 7 | S |   | F | mplementation | CGC,P | C                     |
|   |             | 6 | G |   |   | group C       | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCD2      | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 1 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 7 |             | 7 | S |   | F | mplementation | CGC,P | D2                    |
|   |             | 7 | G |   |   | group D2      | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCE       | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 1 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 8 |             | 7 | S |   | F | mplementation | CGC,P | E                     |
|   |             | 8 | G |   |   | group E       | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCF       | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 1 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 9 |             | 8 | S |   | F | mplementation | CGC,P | F                     |
|   |             | 8 | G |   |   | group F       | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCG       | 2 | E | A | L | FA            | CGC   | Fanconi anemia,       |
| 2 |             | 1 | N | R | o | co            | _94,N | complementation group |
| 0 |             | 8 | S |   | F | mplementation | CGC,P | G                     |
|   |             | 9 | G |   |   | group G       | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCI       | 5 | E | A | L | FA            | N     | Fanconi anemia,       |
| 2 |             | 5 | N | R | o | co            | CGC,P | complementation group |
| 1 |             | 2 | S |   | F | mplementation | ANEL_ | I                     |
|   |             | 1 | G |   |   | group I       | APP,T |                       |
|   |             | 5 | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCL       | 5 | E | A | L | FA            | N     | Fanconi anemia,       |
| 2 |             | 5 | N | R | o | co            | CGC,P | complementation group |
| 2 |             | 1 | S |   | F | mplementation | ANEL_ | L                     |
|   |             | 2 | G |   |   | group L       | APP,T |                       |
|   |             | 0 | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FANCM       | 5 | E | A | L | FA            | N     | NA                    |
| 2 |             | 7 | N | D | o | co            | CGC,P |                       |
| 3 |             | 6 | S | / | F | mplementation | ANEL_ |                       |
|   |             | 9 | G | A |   | group M       | APP,T |                       |
|   |             | 7 | 0 | R |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FAS         | 3 | E | A | L | Fas cell      | P     | Autoimmune            |
| 2 |             | 5 | N | D | o | surface death | ANEL_ | lymphoproliferative   |
| 4 |             | 5 | S |   | F | receptor      | APP,T | syndrome              |
|   |             |   | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FAT1        | 2 | E | N | N | FAT atypical  | C     | NA                    |
| 2 |             | 1 | N | A | A | cadherin 1    | GC_94 |                       |
| 5 |             | 9 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FBXW7       | 5 | E | N | N | F-box and WD  | OTHER | NA                    |
| 2 |             | 5 | N | A | A | repeat domain |       |                       |
| 6 |             | 2 | S |   |   | containing 7  |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FEN1        | 2 | E | N | N | flap          | C     | NA                    |
| 2 |             | 2 | N | A | A | struc         | GC_94 |                       |
| 7 |             | 3 | S |   |   | ture-specific |       |                       |
|   |             | 7 | G |   |   | endonuclease  |       |                       |
|   |             |   | 0 |   |   | 1             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FGF23       | 8 | E | A | N | fibroblast    | PANE  | NA                    |
| 2 |             | 0 | N | D | A | growth factor | L_APP |                       |
| 8 |             | 7 | S | / |   | 23            |       |                       |
|   |             | 4 | G | A |   |               |       |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FGFR1       | 2 | E | A | N | fibroblast    | OTHER | NA                    |
| 2 |             | 2 | N | D | A | growth factor |       |                       |
| 9 |             | 6 | S |   |   | receptor 1    |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FGFR2       | 2 | E | A | N | fibroblast    | PANE  | NA                    |
| 3 |             | 2 | N | D | A | growth factor | L_APP |                       |
| 0 |             | 6 | S |   |   | receptor 2    |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FGFR3       | 2 | E | A | N | fibroblast    | PANE  | NA                    |
| 3 |             | 2 | N | D | A | growth factor | L_APP |                       |
| 1 |             | 6 | S |   |   | receptor 3    |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FH          | 2 | E | A | L | fumarate      | CGC   | Hereditary            |
| 3 |             | 2 | N | D | o | hydratase     | _94,N | leiomyomatosis and    |
| 2 |             | 7 | S | / | F |               | CGC,P | renal cell cancer     |
|   |             | 1 | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FHIT        | 2 | E | N | N | fragile       | OTHER | NA                    |
| 3 |             | 2 | N | A | A | histidine     |       |                       |
| 3 |             | 7 | S |   |   | triad         |       |                       |
|   |             | 2 | G |   |   | diadenosine   |       |                       |
|   |             |   | 0 |   |   | t             |       |                       |
|   |             |   | 0 |   |   | riphosphatase |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FLCN        | 2 | E | A | L | folliculin    | CGC   | NA                    |
| 3 |             | 0 | N | D | o |               | _94,N |                       |
| 4 |             | 1 | S | / | F |               | CGC,P |                       |
|   |             | 1 | G | A |   |               | ANEL_ |                       |
|   |             | 6 | 0 | R |   |               | APP,T |                       |
|   |             | 3 | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FLT3        | 2 | E | N | N | fms related   | OTHER | NA                    |
| 3 |             | 3 | N | A | A | receptor      |       |                       |
| 5 |             | 2 | S |   |   | tyrosine      |       |                       |
|   |             | 2 | G |   |   | kinase 3      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FMR1        | 2 | E | X | N | FMRP          | OTHER | NA                    |
| 3 |             | 3 | N | D | A | translational |       |                       |
| 6 |             | 3 | S |   |   | regulator 1   |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FOXE1       | 2 | E | A | N | forkhead box  | PANE  | NA                    |
| 3 |             | 3 | N | D | A | E1            | L_APP |                       |
| 7 |             | 0 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FOXO1       | 2 | E | N | N | forkhead box  | PANE  | NA                    |
| 3 |             | 3 | N | A | A | O1            | L_APP |                       |
| 8 |             | 0 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FOXO3       | 2 | E | A | N | forkhead box  | PANE  | NA                    |
| 3 |             | 3 | N | D | A | O3            | L_APP |                       |
| 9 |             | 0 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FOXO4       | 4 | E | N | N | forkhead box  | OTHER | NA                    |
| 4 |             | 3 | N | A | A | O4            |       |                       |
| 0 |             | 0 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | FOXP1       | 2 | E | N | N | forkhead box  | OTHER | NA                    |
| 4 |             | 7 | N | A | A | P1            |       |                       |
| 1 |             | 0 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | G6PC1       | 2 | E | N | N | glucose-      | OTHER | NA                    |
| 4 |             | 5 | N | A | A | 6-phosphatase |       |                       |
| 2 |             | 3 | S |   |   | catalytic     |       |                       |
|   |             | 8 | G |   |   | subunit 1     |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GALNT12     | 7 | E | A | L | polypeptide   | NCGC  | NA                    |
| 4 |             | 9 | N | D | o | N-acety       |       |                       |
| 3 |             | 6 | S |   | F | lgalactosamin |       |                       |
|   |             | 9 | G |   |   | yltransferase |       |                       |
|   |             | 5 | 0 |   |   | 12            |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GALNT3      | 2 | E | A | N | polypeptide   | PANE  | NA                    |
| 4 |             | 5 | N | R | A | N-acety       | L_APP |                       |
| 4 |             | 9 | S |   |   | lgalactosamin |       |                       |
|   |             | 1 | G |   |   | yltransferase |       |                       |
|   |             |   | 0 |   |   | 3             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GATA1       | 2 | E | N | N | GATA binding  | PANE  | NA                    |
| 4 |             | 6 | N | A | A | protein 1     | L_APP |                       |
| 5 |             | 2 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GATA2       | 2 | E | A | L | GATA binding  | N     | Dendritic cell,       |
| 4 |             | 6 | N | D | o | protein 2     | CGC,P | monocyte, B           |
| 6 |             | 2 | S |   | F |               | ANEL_ | lymphocyte, and       |
|   |             | 4 | G |   |   |               | APP,T | natural killer        |
|   |             |   | 0 |   |   |               | CGA_P | lymphocyte deficiency |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GATA3       | 2 | E | N | N | GATA binding  | OTHER | NA                    |
| 4 |             | 6 | N | A | A | protein 3     |       |                       |
| 7 |             | 2 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GBA         | 2 | E | A | L | gluco         | P     | NA                    |
| 4 |             | 6 | N | R | o | sylceramidase | ANEL_ |                       |
| 8 |             | 2 | S |   | F | beta          | APP,T |                       |
|   |             | 9 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GDNF        | 2 | E | N | N | glial cell    | PANE  | NA                    |
| 4 |             | 6 | N | A | A | derived       | L_APP |                       |
| 9 |             | 6 | S |   |   | neurotrophic  |       |                       |
|   |             | 8 | G |   |   | factor        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GJB2        | 2 | E | A | L | gap junction  | T     | NA                    |
| 5 |             | 7 | N | D | o | protein beta  | CGA_P |                       |
| 0 |             | 0 | S |   | F | 2             | ANCAN |                       |
|   |             | 6 | G |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GLA         | 2 | E | N | L | galactosidase | ACMG  | Fabry disease         |
| 5 |             | 7 | N | A | o | alpha         | _SF30 |                       |
| 1 |             | 1 | S |   | F |               | ,PANE |                       |
|   |             | 7 | G |   |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GLI3        | 2 | E | A | N | GLI family    | OTHER | NA                    |
| 5 |             | 7 | N | D | A | zinc finger 3 |       |                       |
| 2 |             | 3 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GNAS        | 2 | E | A | N | GNAS complex  | OTHER | NA                    |
| 5 |             | 7 | N | D | A | locus         | ,PANE |                       |
| 3 |             | 7 | S | & |   |               | L_APP |                       |
|   |             | 8 | G | m |   |               |       |                       |
|   |             |   | 0 | o |   |               |       |                       |
|   |             |   | 0 | s |   |               |       |                       |
|   |             |   | 0 | a |   |               |       |                       |
|   |             |   | 0 | i |   |               |       |                       |
|   |             |   | 0 | c |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GPC3        | 2 | E | N | L | glypican 3    | CGC   | Simpson-Golabi-Behmel |
| 5 |             | 7 | N | A | o |               | _94,N | syndrome type 1       |
| 4 |             | 1 | S |   | F |               | CGC,P |                       |
|   |             | 9 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GPC4        | 2 | E | N | N | glypican 4    | OTHER | NA                    |
| 5 |             | 2 | N | A | A |               |       |                       |
| 5 |             | 3 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GPR161      | 2 | E | A | N | G             | PANE  | NA                    |
| 5 |             | 3 | N | D | A | pr            | L_APP |                       |
| 6 |             | 4 | S |   |   | otein-coupled |       |                       |
|   |             | 3 | G |   |   | receptor 161  |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | GREM1       | 2 | E | A | G | gremlin 1,    | NCGC  | NA                    |
| 5 |             | 6 | N | D | o | DAN family    | ,PANE |                       |
| 7 |             | 5 | S |   | F | BMP           | L_APP |                       |
|   |             | 8 | G |   |   | antagonist    |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | H19         | 2 | E | N | N | H19 imprinted | PANE  | NA                    |
| 5 |             | 8 | N | A | A | maternally    | L_APP |                       |
| 8 |             | 3 | S |   |   | expressed     |       |                       |
|   |             | 1 | G |   |   | transcript    |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HABP2       | 3 | E | A | N | hyaluronan    | NCGC  | NA                    |
| 5 |             | 0 | N | D | A | binding       | ,PANE |                       |
| 9 |             | 2 | S |   |   | protein 2     | L_APP |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HAX1        | 1 | E | A | N | HCLS1         | PANE  | NA                    |
| 6 |             | 0 | N | R | A | associated    | L_APP |                       |
| 0 |             | 4 | S |   |   | protein X-1   |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HFE         | 3 | E | A | L | homeostatic   | A     | Hereditary            |
| 6 |             | 0 | N | R | o | iron          | CMG_S | hemochromatosis       |
| 1 |             | 7 | S |   | F | regulator     | F30,T |                       |
|   |             | 7 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HMBS        | 3 | E | A | L | hydrox        | T     | NA                    |
| 6 |             | 1 | N | D | o | ymethylbilane | CGA_P |                       |
| 2 |             | 4 | S |   | F | synthase      | ANCAN |                       |
|   |             | 5 | G |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HNF1A       | 6 | E | A | L | HNF1 homeobox | ACM   | Hepatic adenomas,     |
| 6 |             | 9 | N | R | o | A             | G_SF3 | familial; NA          |
| 3 |             | 2 | S |   | F |               | 0,CGC |                       |
|   |             | 7 | G |   |   |               | _94,N |                       |
|   |             |   | 0 |   |   |               | CGC,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HNF1B       | 6 | E | N | N | HNF1 homeobox | NCGC  | NA                    |
| 6 |             | 9 | N | A | A | B             |       |                       |
| 4 |             | 2 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HOXB13      | 1 | E | A | N | homeobox B13  | NCGC  | NA                    |
| 6 |             | 0 | N | D | A |               | ,PANE |                       |
| 5 |             | 4 | S |   |   |               | L_APP |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | HRAS        | 3 | E | A | G | HRas          | CGC   | Costello syndrome     |
| 6 |             | 2 | N | D | o | pr            | _94,N |                       |
| 6 |             | 6 | S |   | F | oto-oncogene, | CGC,P |                       |
|   |             | 5 | G |   |   | GTPase        | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IDH1        | 3 | E | N | N | isocitrate    | OTHER | NA                    |
| 6 |             | 4 | N | A | A | dehydrogenase |       |                       |
| 7 |             | 1 | S |   |   | (NADP(+)) 1   |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IGF2        | 3 | E | N | N | insulin like  | PANE  | NA                    |
| 6 |             | 4 | N | A | A | growth factor | L_APP |                       |
| 8 |             | 8 | S |   |   | 2             |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IGF2R       | 3 | E | N | N | insulin like  | OTHER | NA                    |
| 6 |             | 4 | N | A | A | growth factor |       |                       |
| 9 |             | 8 | S |   |   | 2 receptor    |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IKZF1       | 1 | E | A | N | IKAROS family | OTHER | NA                    |
| 7 |             | 0 | N | D | A | zinc finger 1 | ,PANE |                       |
| 0 |             | 3 | S |   |   |               | L_APP |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IKZF3       | 2 | E | N | N | IKAROS family | OTHER | NA                    |
| 7 |             | 2 | N | A | A | zinc finger 3 |       |                       |
| 1 |             | 8 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | IRF4        | 3 | E | A | N | interferon    | PANE  | NA                    |
| 7 |             | 6 | N | D | A | regulatory    | L_APP |                       |
| 2 |             | 6 | S |   |   | factor 4      |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | ITK         | 3 | E | A | L | IL2 inducible | P     | Lymphoproliferative   |
| 7 |             | 7 | N | R | o | T cell kinase | ANEL_ | syndrome 1            |
| 3 |             | 0 | S |   | F |               | APP,T |                       |
|   |             | 2 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | JAK1        | 3 | E | N | N | Janus kinase  | OTHER | NA                    |
| 7 |             | 7 | N | A | A | 1             |       |                       |
| 4 |             | 1 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | JAK2        | 3 | E | A | N | Janus kinase  | PANE  | NA                    |
| 7 |             | 7 | N | D | A | 2             | L_APP |                       |
| 5 |             | 1 | S | / |   |               |       |                       |
|   |             | 7 | G | A |   |               |       |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | JAK3        | 3 | E | A | N | Janus kinase  | OTHER | NA                    |
| 7 |             | 7 | N | R | A | 3             |       |                       |
| 6 |             | 1 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | JMJD1C      | 2 | E | A | N | jumonji       | T     | NA                    |
| 7 |             | 2 | N | D | A | domain        | CGA_P |                       |
| 7 |             | 1 | S |   |   | containing 1C | ANCAN |                       |
|   |             | 0 | G |   |   |               | _2018 |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KCNQ1       | 3 | E | A | L | potassium     | ACMG_ | Long QT syndrome 1    |
| 7 |             | 7 | N | D | o | voltage-gated | SF30, |                       |
| 8 |             | 8 | S |   | F | channel       | OTHER |                       |
|   |             | 4 | G |   |   | subfamily Q   |       |                       |
|   |             |   | 0 |   |   | member 1      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KCNQ1OT1    | 1 | E | N | N | KCNQ1         | PANE  | NA                    |
| 7 |             | 0 | N | A | A | opposite      | L_APP |                       |
| 9 |             | 9 | S |   |   | str           |       |                       |
|   |             | 8 | G |   |   | and/antisense |       |                       |
|   |             | 4 | 0 |   |   | transcript 1  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KDM3B       | 5 | E | N | N | lysine        | OTHER | NA                    |
| 8 |             | 1 | N | A | A | demethylase   |       |                       |
| 0 |             | 7 | S |   |   | 3B            |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KDR         | 3 | E | A | N | kinase insert | C     | NA                    |
| 8 |             | 7 | N | D | A | domain        | GC_94 |                       |
| 1 |             | 9 | S |   |   | receptor      |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KIF1B       | 2 | E | N | N | kinesin       | NCGC  | NA                    |
| 8 |             | 3 | N | A | A | family member | ,PANE |                       |
| 2 |             | 0 | S |   |   | 1B            | L_APP |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KISS1R      | 8 | E | N | N | KISS1         | PANE  | NA                    |
| 8 |             | 4 | N | A | A | receptor      | L_APP |                       |
| 3 |             | 6 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KIT         | 3 | E | A | G | KIT           | CGC   | Gastrointestinal      |
| 8 |             | 8 | N | D | o | pr            | _94,N | stromal tumor         |
| 4 |             | 1 | S |   | F | oto-oncogene, | CGC,P |                       |
|   |             | 5 | G |   |   | receptor      | ANEL_ |                       |
|   |             |   | 0 |   |   | tyrosine      | APP,T |                       |
|   |             |   | 0 |   |   | kinase        | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KITLG       | 4 | E | A | N | KIT ligand    | PANE  | NA                    |
| 8 |             | 2 | N | D | A |               | L_APP |                       |
| 5 |             | 5 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KLF6        | 1 | E | N | N | Kruppel like  | OTHER | NA                    |
| 8 |             | 3 | N | A | A | factor 6      |       |                       |
| 6 |             | 1 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KLLN        | 1 | E | N | N | killin, p53   | PANE  | NA                    |
| 8 |             | 0 | N | A | A | regulated DNA | L_APP |                       |
| 7 |             | 0 | S |   |   | replication   |       |                       |
|   |             | 1 | G |   |   | inhibitor     |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KMT2D       | 8 | E | N | N | lysine        | OTHER | NA                    |
| 8 |             | 0 | N | A | A | meth          |       |                       |
| 8 |             | 8 | S |   |   | yltransferase |       |                       |
|   |             | 5 | G |   |   | 2D            |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KRAS        | 3 | E | A | N | KRAS          | P     | Noonan syndrome 3;    |
| 8 |             | 8 | N | D | A | pr            | ANEL_ | RAS-associated        |
| 9 |             | 4 | S | / |   | oto-oncogene, | APP,T | autoimmune            |
|   |             | 5 | G | A |   | GTPase        | CGA_P | leukoproliferative    |
|   |             |   | 0 | R |   |               | ANCAN | disorder              |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | KRT17       | 3 | E | A | N | keratin 17    | PANE  | NA                    |
| 9 |             | 8 | N | D | A |               | L_APP |                       |
| 0 |             | 7 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | L2HGDH      | 7 | E | A | N | L-2-hyd       | OTHER | NA                    |
| 9 |             | 9 | N | R | A | roxyglutarate |       |                       |
| 1 |             | 9 | S |   |   | dehydrogenase |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LCK         | 3 | E | A | N | LCK           | OTHER | NA                    |
| 9 |             | 9 | N | R | A | pr            |       |                       |
| 2 |             | 3 | S |   |   | oto-oncogene, |       |                       |
|   |             | 2 | G |   |   | Src family    |       |                       |
|   |             |   | 0 |   |   | tyrosine      |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LEF1        | 5 | E | A | N | lymphoid      | PANE  | NA                    |
| 9 |             | 1 | N | D | A | enhancer      | L_APP |                       |
| 3 |             | 1 | S |   |   | binding       |       |                       |
|   |             | 7 | G |   |   | factor 1      |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LEMD3       | 2 | E | A | N | LEM domain    | PANE  | NA                    |
| 9 |             | 3 | N | D | A | containing 3  | L_APP |                       |
| 4 |             | 5 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LIG4        | 3 | E | A | N | DNA ligase 4  | PANE  | NA                    |
| 9 |             | 9 | N | R | A |               | L_APP |                       |
| 5 |             | 8 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LMO1        | 4 | E | A | N | LIM domain    | CGC   | Neuroblastoma,        |
| 9 |             | 0 | N | D | A | only 1        | _94,T | susceptibility to, 7  |
| 6 |             | 0 | S |   |   |               | CGA_P |                       |
|   |             | 4 | G |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LRIG3       | 1 | E | N | N | leucine rich  | OTHER | NA                    |
| 9 |             | 2 | N | A | A | repeats and   |       |                       |
| 7 |             | 1 | S |   |   | i             |       |                       |
|   |             | 2 | G |   |   | mmunoglobulin |       |                       |
|   |             | 2 | 0 |   |   | like domains  |       |                       |
|   |             | 7 | 0 |   |   | 3             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | LZTR1       | 8 | E | A | N | leucine       | C     | NA                    |
| 9 |             | 2 | N | D | A | zipper like   | GC_94 |                       |
| 8 |             | 1 | S | / |   | transcription | ,NCGC |                       |
|   |             | 6 | G | A |   | regulator 1   | ,PANE |                       |
|   |             |   | 0 | R |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 1 | MAD2L2      | 1 | E | A | N | mitotic       | PANE  | NA                    |
| 9 |             | 0 | N | R | A | arrest        | L_APP |                       |
| 9 |             | 4 | S |   |   | deficient 2   |       |                       |
|   |             | 5 | G |   |   | like 2        |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAF         | 4 | E | N | N | MAF bZIP      | OTHER | NA                    |
| 0 |             | 0 | N | A | A | transcription |       |                       |
| 0 |             | 9 | S |   |   | factor        |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAFB        | 9 | E | N | N | MAF bZIP      | OTHER | NA                    |
| 0 |             | 9 | N | A | A | transcription |       |                       |
| 1 |             | 3 | S |   |   | factor B      |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAP2K1      | 5 | E | A | N | mito          | P     | NA                    |
| 0 |             | 6 | N | D | A | gen-activated | ANEL_ |                       |
| 2 |             | 0 | S |   |   | protein       | APP,T |                       |
|   |             | 4 | G |   |   | kinase kinase | CGA_P |                       |
|   |             |   | 0 |   |   | 1             | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAP2K2      | 5 | E | A | N | mito          | P     | NA                    |
| 0 |             | 6 | N | D | A | gen-activated | ANEL_ |                       |
| 3 |             | 0 | S |   |   | protein       | APP,T |                       |
|   |             | 5 | G |   |   | kinase kinase | CGA_P |                       |
|   |             |   | 0 |   |   | 2             | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAP2K4      | 6 | E | N | N | mito          | OTHER | NA                    |
| 0 |             | 4 | N | A | A | gen-activated |       |                       |
| 4 |             | 1 | S |   |   | protein       |       |                       |
|   |             | 6 | G |   |   | kinase kinase |       |                       |
|   |             |   | 0 |   |   | 4             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAP3K1      | 4 | E | N | N | mito          | NCGC  | NA                    |
| 0 |             | 2 | N | A | A | gen-activated |       |                       |
| 5 |             | 1 | S |   |   | protein       |       |                       |
|   |             | 4 | G |   |   | kinase kinase |       |                       |
|   |             |   | 0 |   |   | kinase 1      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MAX         | 4 | E | A | L | MYC           | ACM   | Hereditary            |
| 0 |             | 1 | N | D | o | associated    | G_SF3 | Paragangl             |
| 6 |             | 4 | S | / | F | factor X      | 0,CGC | ioma-Pheochromocytoma |
|   |             | 9 | G | A |   |               | _94,N | Syndromes             |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MBD4        | 8 | E | A | N | methyl-CpG    | PANE  | NA                    |
| 0 |             | 9 | N | R | A | binding       | L_APP |                       |
| 7 |             | 3 | S |   |   | domain 4, DNA |       |                       |
|   |             | 0 | G |   |   | glycosylase   |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MC1R        | 4 | E | A | N | melanocortin  | PANE  | NA                    |
| 0 |             | 1 | N | R | A | 1 receptor    | L_APP |                       |
| 8 |             | 5 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MDH2        | 4 | E | A | N | malate        | PANE  | NA                    |
| 0 |             | 1 | N | D | A | dehydrogenase | L_APP |                       |
| 9 |             | 9 | S |   |   | 2             |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MEN1        | 4 | E | A | L | menin 1       | ACM   | Multiple endocrine    |
| 1 |             | 2 | N | D | o |               | G_SF3 | neoplasia, type 1     |
| 0 |             | 2 | S | / | F |               | 0,CGC |                       |
|   |             | 1 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MET         | 4 | E | A | G | MET           | N     | Renal cell carcinoma  |
| 1 |             | 2 | N | D | o | pr            | CGC,P |                       |
| 1 |             | 3 | S |   | F | oto-oncogene, | ANEL_ |                       |
|   |             | 3 | G |   |   | receptor      | APP,T |                       |
|   |             |   | 0 |   |   | tyrosine      | CGA_P |                       |
|   |             |   | 0 |   |   | kinase        | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MINPP1      | 9 | E | A | N | multiple      | PANE  | NA                    |
| 1 |             | 5 | N | D | A | inositol-     | L_APP |                       |
| 2 |             | 6 | S |   |   | polyphosphate |       |                       |
|   |             | 2 | G |   |   | phosphatase 1 |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MITF        | 4 | E | A | G | melanocyte    | N     | Hereditary melanoma   |
| 1 |             | 2 | N | D | o | inducing      | CGC,P |                       |
| 3 |             | 8 | S |   | F | transcription | ANEL_ |                       |
|   |             | 6 | G |   |   | factor        | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MLH1        | 4 | E | A | L | mutL homolog  | ACM   | Hereditary            |
| 1 |             | 2 | N | D | o | 1             | G_SF3 | nonpolyposis          |
| 4 |             | 9 | S | / | F |               | 0,CGC | colorectal neoplasms; |
|   |             | 2 | G | A |   |               | _94,N | Turcot syndrome;      |
|   |             |   | 0 | R |   |               | CGC,P | Hereditary            |
|   |             |   | 0 |   |   |               | ANEL_ | nonpolyposis colon    |
|   |             |   | 0 |   |   |               | APP,T | cancer; Lynch         |
|   |             |   | 0 |   |   |               | CGA_P | syndrome              |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MLH3        | 2 | E | N | N | mutL homolog  | NCGC  | NA                    |
| 1 |             | 7 | N | A | A | 3             |       |                       |
| 5 |             | 0 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MN1         | 4 | E | A | N | MN1           | OTHER | NA                    |
| 1 |             | 3 | N | D | A | pr            |       |                       |
| 6 |             | 3 | S |   |   | oto-oncogene, |       |                       |
|   |             | 0 | G |   |   | tr            |       |                       |
|   |             |   | 0 |   |   | anscriptional |       |                       |
|   |             |   | 0 |   |   | regulator     |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MPL         | 4 | E | A | N | MPL           | CGC   | NA                    |
| 1 |             | 3 | N | D | A | pr            | _94,T |                       |
| 7 |             | 5 | S |   |   | oto-oncogene, | CGA_P |                       |
|   |             | 2 | G |   |   | t             | ANCAN |                       |
|   |             |   | 0 |   |   | hrombopoietin | _2018 |                       |
|   |             |   | 0 |   |   | receptor      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MRE11       | 4 | E | N | N | MRE11         | NCGC  | NA                    |
| 1 |             | 3 | N | A | A | homolog,      |       |                       |
| 8 |             | 6 | S |   |   | double strand |       |                       |
|   |             | 1 | G |   |   | break repair  |       |                       |
|   |             |   | 0 |   |   | nuclease      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MSH2        | 4 | E | A | L | mutS homolog  | ACM   | Hereditary            |
| 1 |             | 4 | N | D | o | 2             | G_SF3 | nonpolyposis          |
| 9 |             | 3 | S | / | F |               | 0,CGC | colorectal neoplasms; |
|   |             | 6 | G | A |   |               | _94,N | Turcot syndrome;      |
|   |             |   | 0 | R |   |               | CGC,P | Hereditary            |
|   |             |   | 0 |   |   |               | ANEL_ | nonpolyposis colon    |
|   |             |   | 0 |   |   |               | APP,T | cancer; Lynch         |
|   |             |   | 0 |   |   |               | CGA_P | syndrome              |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MSH3        | 4 | E | A | N | mutS homolog  | NCGC  | NA                    |
| 2 |             | 4 | N | R | A | 3             | ,PANE |                       |
| 0 |             | 3 | S |   |   |               | L_APP |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MSH5        | 4 | E | N | N | mutS homolog  | PANE  | NA                    |
| 2 |             | 4 | N | A | A | 5             | L_APP |                       |
| 1 |             | 3 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MSH6        | 2 | E | A | L | mutS homolog  | ACM   | Hereditary            |
| 2 |             | 9 | N | D | o | 6             | G_SF3 | nonpolyposis          |
| 2 |             | 5 | S | / | F |               | 0,CGC | colorectal neoplasms; |
|   |             | 6 | G | A |   |               | _94,N | Turcot syndrome;      |
|   |             |   | 0 | R |   |               | CGC,P | Hereditary            |
|   |             |   | 0 |   |   |               | ANEL_ | nonpolyposis colon    |
|   |             |   | 0 |   |   |               | APP,T | cancer; Lynch         |
|   |             |   | 0 |   |   |               | CGA_P | syndrome              |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MSR1        | 4 | E | A | N | macrophage    | PANE  | NA                    |
| 2 |             | 4 | N | D | A | scavenger     | L_APP |                       |
| 3 |             | 8 | S |   |   | receptor 1    |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MTAP        | 4 | E | A | L | methyl        | P     | Diaphyseal medullary  |
| 2 |             | 5 | N | D | o | thioadenosine | ANEL_ | stenosis-bone         |
| 4 |             | 0 | S |   | F | phosphorylase | APP,T | malignancy syndrome   |
|   |             | 7 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MUC1        | 4 | E | A | N | mucin 1, cell | OTHER | NA                    |
| 2 |             | 5 | N | D | A | surface       |       |                       |
| 5 |             | 8 | S |   |   | associated    |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MUC5B       | 7 | E | N | N | mucin 5B,     | OTHER | NA                    |
| 2 |             | 2 | N | A | A | oligomeric    |       |                       |
| 6 |             | 7 | S |   |   | mucu          |       |                       |
|   |             | 8 | G |   |   | s/gel-forming |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MUTYH       | 4 | E | A | L | mutY DNA      | ACM   | MYH-associated        |
| 2 |             | 5 | N | R | o | glycosylase   | G_SF3 | polyposis             |
| 7 |             | 9 | S |   | F |               | 0,CGC |                       |
|   |             | 5 | G |   |   |               | _94,N |                       |
|   |             |   | 0 |   |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | MYCN        | 4 | E | N | N | MYCN          | OTHER | NA                    |
| 2 |             | 6 | N | A | A | pr            |       |                       |
| 8 |             | 1 | S |   |   | oto-oncogene, |       |                       |
|   |             | 3 | G |   |   | bHLH          |       |                       |
|   |             |   | 0 |   |   | transcription |       |                       |
|   |             |   | 0 |   |   | factor        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NAF1        | 9 | E | A | N | nuclear       | PANE  | NA                    |
| 2 |             | 2 | N | D | A | assembly      | L_APP |                       |
| 9 |             | 3 | S |   |   | factor 1      |       |                       |
|   |             | 4 | G |   |   | ribo          |       |                       |
|   |             | 5 | 0 |   |   | nucleoprotein |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NBN         | 4 | E | A | L | nibrin        | CGC   | Microcephaly, normal  |
| 3 |             | 6 | N | R | o |               | _94,N | intelligence and      |
| 0 |             | 8 | S |   | F |               | CGC,P | immunodeficiency      |
|   |             | 3 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NCOA4       | 8 | E | N | N | nuclear       | OTHER | NA                    |
| 3 |             | 0 | N | A | A | receptor      |       |                       |
| 1 |             | 3 | S |   |   | coactivator 4 |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NDRG1       | 1 | E | N | N | N-myc         | OTHER | NA                    |
| 3 |             | 0 | N | A | A | downstream    |       |                       |
| 2 |             | 3 | S |   |   | regulated 1   |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NDUFA13     | 5 | E | A | N | NA            | PANE  | NA                    |
| 3 |             | 1 | N | D | A | DH:ubiquinone | L_APP |                       |
| 3 |             | 0 | S |   |   | o             |       |                       |
|   |             | 7 | G |   |   | xidoreductase |       |                       |
|   |             | 9 | 0 |   |   | subunit A13   |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NF1         | 4 | E | A | L | neurofibromin | CGC   | Neurofibromatosis,    |
| 3 |             | 7 | N | D | o | 1             | _94,N | type 1                |
| 4 |             | 6 | S | / | F |               | CGC,P |                       |
|   |             | 3 | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NF2         | 4 | E | A | L | neurofibromin | ACM   | Neurofibromatosis,    |
| 3 |             | 7 | N | D | o | 2             | G_SF3 | type 2                |
| 5 |             | 7 | S | / | F |               | 0,CGC |                       |
|   |             | 1 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NFIX        | 4 | E | N | N | nuclear       | PANE  | NA                    |
| 3 |             | 7 | N | A | A | factor I X    | L_APP |                       |
| 6 |             | 8 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NHP2        | 5 | E | A | N | NHP2          | P     | Dyskeratosis          |
| 3 |             | 5 | N | R | A | ribo          | ANEL_ | congenita, autosomal  |
| 7 |             | 6 | S |   |   | nucleoprotein | APP,T | recessive 2           |
|   |             | 5 | G |   |   |               | CGA_P |                       |
|   |             | 1 | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NKX2-1      | 7 | E | A | N | NK2 homeobox  | PANE  | NA                    |
| 3 |             | 0 | N | D | A | 1             | L_APP |                       |
| 8 |             | 8 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NOP10       | 5 | E | A | N | NOP10         | P     | Dyskeratosis          |
| 3 |             | 5 | N | R | A | ribo          | ANEL_ | congenita autosomal   |
| 9 |             | 5 | S |   |   | nucleoprotein | APP,T | recessive 1           |
|   |             | 0 | G |   |   |               | CGA_P |                       |
|   |             | 5 | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NOTCH1      | 4 | E | N | N | notch         | OTHER | NA                    |
| 4 |             | 8 | N | A | A | receptor 1    |       |                       |
| 0 |             | 5 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NOTCH3      | 4 | E | A | N | notch         | NCGC  | NA                    |
| 4 |             | 8 | N | D | A | receptor 3    | ,PANE |                       |
| 1 |             | 5 | S |   |   |               | L_APP |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NR4A3       | 8 | E | N | N | nuclear       | OTHER | NA                    |
| 4 |             | 0 | N | A | A | receptor      |       |                       |
| 2 |             | 1 | S |   |   | subfamily 4   |       |                       |
|   |             | 3 | G |   |   | group A       |       |                       |
|   |             |   | 0 |   |   | member 3      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NRAS        | 4 | E | A | N | NRAS          | P     | NA; Epidermal nevus;  |
| 4 |             | 8 | N | D | A | pr            | ANEL_ | Large congenital      |
| 3 |             | 9 | S |   |   | oto-oncogene, | APP,T | melanocytic nevus;    |
|   |             | 3 | G |   |   | GTPase        | CGA_P | RAS-associated        |
|   |             |   | 0 |   |   |               | ANCAN | autoimmune            |
|   |             |   | 0 |   |   |               | _2018 | leukoproliferative    |
|   |             |   | 0 |   |   |               |       | disorder; Noonan      |
|   |             |   | 0 |   |   |               |       | syndrome 6; Rasopathy |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NSD1        | 6 | E | A | L | nuclear       | NCGC  | NA                    |
| 4 |             | 4 | N | D | o | receptor      | ,PANE |                       |
| 4 |             | 3 | S |   | F | binding SET   | L_APP |                       |
|   |             | 2 | G |   |   | domain        |       |                       |
|   |             | 4 | 0 |   |   | protein 1     |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NTHL1       | 4 | E | A | N | nth like DNA  | CGC   | Familial adenomatous  |
| 4 |             | 9 | N | R | A | glycosylase 1 | _94,N | polyposis 3           |
| 5 |             | 1 | S |   |   |               | CGC,P |                       |
|   |             | 3 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NTRK1       | 4 | E | A | N | neurotrophic  | PANE  | NA                    |
| 4 |             | 9 | N | D | A | receptor      | L_APP |                       |
| 6 |             | 1 | S |   |   | tyrosine      |       |                       |
|   |             | 4 | G |   |   | kinase 1      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NTRK3       | 4 | E | N | N | neurotrophic  | OTHER | NA                    |
| 4 |             | 9 | N | A | A | receptor      |       |                       |
| 7 |             | 1 | S |   |   | tyrosine      |       |                       |
|   |             | 6 | G |   |   | kinase 3      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | NYNRIN      | 5 | E | N | N | NYN domain    | OTHER | NA                    |
| 4 |             | 7 | N | A | A | and           |       |                       |
| 8 |             | 5 | S |   |   | retroviral    |       |                       |
|   |             | 2 | G |   |   | integrase     |       |                       |
|   |             | 3 | 0 |   |   | containing    |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | OGG1        | 4 | E | N | N | 8-oxoguanine  | NCGC  | NA                    |
| 4 |             | 9 | N | A | A | DNA           |       |                       |
| 9 |             | 6 | S |   |   | glycosylase   |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PALB2       | 7 | E | A | L | partner and   | ACM   | Familial cancer of    |
| 5 |             | 9 | N | D | o | localizer of  | G_SF3 | breast; Fanconi       |
| 0 |             | 7 | S | / | F | BRCA2         | 0,CGC | anemia,               |
|   |             | 2 | G | A |   |               | _94,N | complementation group |
|   |             | 8 | 0 | R |   |               | CGC,P | N                     |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PARN        | 5 | E | A | N | pol           | PANE  | NA                    |
| 5 |             | 0 | N | D | A | y(A)-specific | L_APP |                       |
| 1 |             | 7 | S | / |   | ribonuclease  |       |                       |
|   |             | 3 | G | A |   |               |       |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PAX3        | 5 | E | N | N | paired box 3  | PANE  | NA                    |
| 5 |             | 0 | N | A | A |               | L_APP |                       |
| 2 |             | 7 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PAX5        | 5 | E | A | N | paired box 5  | N     | Leukemia, acute       |
| 5 |             | 0 | N | D | A |               | CGC,P | lymphoblastic,        |
| 3 |             | 7 | S |   |   |               | ANEL_ | susceptibility to, 3  |
|   |             | 9 | G |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PAX6        | 5 | E | A | N | paired box 6  | PANE  | NA                    |
| 5 |             | 0 | N | D | A |               | L_APP |                       |
| 4 |             | 8 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PAX7        | 5 | E | N | N | paired box 7  | PANE  | NA                    |
| 5 |             | 0 | N | A | A |               | L_APP |                       |
| 5 |             | 8 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PBRM1       | 5 | E | N | N | polybromo 1   | OTHER | NA                    |
| 5 |             | 5 | N | A | A |               |       |                       |
| 6 |             | 1 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PDGFRA      | 5 | E | A | G | platelet      | CGC   | Gastrointestinal      |
| 5 |             | 1 | N | D | o | derived       | _94,N | stromal tumor         |
| 7 |             | 5 | S |   | F | growth factor | CGC,P |                       |
|   |             | 6 | G |   |   | receptor      | ANEL_ |                       |
|   |             |   | 0 |   |   | alpha         | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PDGFRB      | 5 | E | A | N | platelet      | PANE  | NA                    |
| 5 |             | 1 | N | D | A | derived       | L_APP |                       |
| 8 |             | 5 | S |   |   | growth factor |       |                       |
|   |             | 9 | G |   |   | receptor beta |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PHF6        | 8 | E | N | N | PHD finger    | OTHER | NA                    |
| 5 |             | 4 | N | A | A | protein 6     |       |                       |
| 9 |             | 2 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PHOX2B      | 8 | E | A | L | paired like   | CGC   | Neuroblastoma 2       |
| 6 |             | 9 | N | D | o | homeobox 2B   | _94,N |                       |
| 0 |             | 2 | S | / | F |               | CGC,P |                       |
|   |             | 9 | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PIK3CA      | 5 | E | A | G | phosphatidy   | NCGC  | NA                    |
| 6 |             | 2 | N | D | o | linositol-4,5 | ,PANE |                       |
| 1 |             | 9 | S |   | F | -bisphosphate | L_APP |                       |
|   |             | 0 | G |   |   | 3-kinase      |       |                       |
|   |             |   | 0 |   |   | catalytic     |       |                       |
|   |             |   | 0 |   |   | subunit alpha |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PINK1       | 6 | E | N | N | PTEN induced  | NCGC  | NA                    |
| 6 |             | 5 | N | A | A | kinase 1      |       |                       |
| 2 |             | 0 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PML         | 5 | E | N | N | PML nuclear   | OTHER | NA                    |
| 6 |             | 3 | N | A | A | body scaffold |       |                       |
| 3 |             | 7 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PMS1        | 5 | E | A | N | PMS1 homolog  | CGC   | NA                    |
| 6 |             | 3 | N | R | A | 1, mismatch   | _94,N |                       |
| 4 |             | 7 | S |   |   | repair system | CGC,T |                       |
|   |             | 8 | G |   |   | component     | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PMS2        | 5 | E | A | L | PMS1 homolog  | ACM   | Hereditary            |
| 6 |             | 3 | N | D | o | 2, mismatch   | G_SF3 | nonpolyposis          |
| 5 |             | 9 | S | / | F | repair system | 0,CGC | colorectal neoplasms; |
|   |             | 5 | G | A |   | component     | _94,N | Turcot syndrome;      |
|   |             |   | 0 | R |   |               | CGC,P | Hereditary            |
|   |             |   | 0 |   |   |               | ANEL_ | nonpolyposis colon    |
|   |             |   | 0 |   |   |               | APP,T | cancer; Lynch         |
|   |             |   | 0 |   |   |               | CGA_P | syndrome              |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POLA1       | 5 | E | N | N | DNA           | PANE  | NA                    |
| 6 |             | 4 | N | A | A | polymerase    | L_APP |                       |
| 6 |             | 2 | S |   |   | alpha 1,      |       |                       |
|   |             | 2 | G |   |   | catalytic     |       |                       |
|   |             |   | 0 |   |   | subunit       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POLD1       | 5 | E | A | L | DNA           | CGC   | NA                    |
| 6 |             | 4 | N | D | o | polymerase    | _94,N |                       |
| 7 |             | 2 | S |   | F | delta 1,      | CGC,P |                       |
|   |             | 4 | G |   |   | catalytic     | ANEL_ |                       |
|   |             |   | 0 |   |   | subunit       | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POLE        | 5 | E | A | L | DNA           | CGC   | NA                    |
| 6 |             | 4 | N | D | o | polymerase    | _94,N |                       |
| 8 |             | 2 | S | / | F | epsilon,      | CGC,P |                       |
|   |             | 6 | G | A |   | catalytic     | ANEL_ |                       |
|   |             |   | 0 | R |   | subunit       | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POLH        | 5 | E | A | L | DNA           | P     | Xeroderma pigmentosum |
| 6 |             | 4 | N | R | o | polymerase    | ANEL_ | variant type          |
| 9 |             | 2 | S |   | F | eta           | APP,T |                       |
|   |             | 9 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POLQ        | 1 | E | N | N | DNA           | C     | NA                    |
| 7 |             | 0 | N | A | A | polymerase    | GC_94 |                       |
| 0 |             | 7 | S |   |   | theta         |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PORCN       | 6 | E | N | N | porcupine     | PANE  | NA                    |
| 7 |             | 4 | N | A | A | O-ac          | L_APP |                       |
| 1 |             | 8 | S |   |   | yltransferase |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | POT1        | 2 | E | A | N | protection of | N     | Melanoma, cutaneous   |
| 7 |             | 5 | N | D | A | telomeres 1   | CGC,P | malignant,            |
| 2 |             | 9 | S |   |   |               | ANEL_ | susceptibility to, 10 |
|   |             | 1 | G |   |   |               | APP,T |                       |
|   |             | 3 | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PPM1D       | 8 | E | N | L | protein       | NCGC  | NA                    |
| 7 |             | 4 | N | A | o | phosphatase,  | ,PANE |                       |
| 3 |             | 9 | S |   | F | Mg2+/Mn2+     | L_APP |                       |
|   |             | 3 | G |   |   | dependent 1D  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PPP1CB      | 5 | E | A | N | protein       | PANE  | NA                    |
| 7 |             | 5 | N | D | A | phosphatase 1 | L_APP |                       |
| 4 |             | 0 | S |   |   | catalytic     |       |                       |
|   |             | 0 | G |   |   | subunit beta  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRDM1       | 6 | E | N | N | PR/SET domain | OTHER | NA                    |
| 7 |             | 3 | N | A | A | 1             |       |                       |
| 5 |             | 9 | S |   |   |               |       |                       |
|   |             |   | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRDM9       | 5 | E | A | N | PR/SET domain | T     | NA                    |
| 7 |             | 6 | N | D | A | 9             | CGA_P |                       |
| 6 |             | 9 | S |   |   |               | ANCAN |                       |
|   |             | 7 | G |   |   |               | _2018 |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRF1        | 5 | E | A | L | perforin 1    | CGC   | Familial              |
| 7 |             | 5 | N | R | o |               | _94,N | hemophagocytic        |
| 7 |             | 5 | S |   | F |               | CGC,P | lymphohistiocytosis 2 |
|   |             | 1 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRKAR1A     | 5 | E | A | L | protein       | CGC   | Carney complex        |
| 7 |             | 5 | N | D | o | kinase        | _94,N |                       |
| 8 |             | 7 | S | / | F | c             | CGC,P |                       |
|   |             | 3 | G | A |   | AMP-dependent | ANEL_ |                       |
|   |             |   | 0 | R |   | type I        | APP,T |                       |
|   |             |   | 0 |   |   | regulatory    | CGA_P |                       |
|   |             |   | 0 |   |   | subunit alpha | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRKN        | 5 | E | N | N | parkin RBR E3 | OTHER | NA                    |
| 7 |             | 0 | N | A | A | ubiquitin     |       |                       |
| 9 |             | 7 | S |   |   | protein       |       |                       |
|   |             | 1 | G |   |   | ligase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PRSS1       | 5 | E | A | L | serine        | N     | Hereditary            |
| 8 |             | 6 | N | D | o | protease 1    | CGC,P | pancreatitis          |
| 0 |             | 4 | S |   | F |               | ANEL_ |                       |
|   |             | 4 | G |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTCH1       | 5 | E | A | L | patched 1     | CGC   | Gorlin syndrome       |
| 8 |             | 7 | N | D | o |               | _94,N |                       |
| 1 |             | 2 | S | / | F |               | CGC,P |                       |
|   |             | 7 | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTCH2       | 8 | E | A | N | patched 2     | PANE  | NA                    |
| 8 |             | 6 | N | D | A |               | L_APP |                       |
| 2 |             | 4 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTCSC1      | 1 | E | A | N | papillary     | PANE  | NA                    |
| 8 |             | 0 | N | D | A | thyroid       | L_APP |                       |
| 3 |             | 0 | S |   |   | carcinoma     |       |                       |
|   |             | 3 | G |   |   | s             |       |                       |
|   |             | 0 | 0 |   |   | usceptibility |       |                       |
|   |             | 2 | 0 |   |   | candidate 1   |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTCSC3      | 1 | N | N | N | papillary     | PANE  | NA                    |
| 8 |             | 0 | A | A | A | thyroid       | L_APP |                       |
| 4 |             | 0 |   |   |   | carcinoma     |       |                       |
|   |             | 8 |   |   |   | s             |       |                       |
|   |             | 8 |   |   |   | usceptibility |       |                       |
|   |             | 6 |   |   |   | candidate 3   |       |                       |
|   |             | 9 |   |   |   |               |       |                       |
|   |             | 6 |   |   |   |               |       |                       |
|   |             | 4 |   |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTEN        | 5 | E | A | L | phosphatase   | ACM   | PTEN hamartoma tumor  |
| 8 |             | 7 | N | D | o | and tensin    | G_SF3 | syndrome; Cowden      |
| 5 |             | 2 | S | / | F | homolog       | 0,CGC | syndrome 1            |
|   |             | 8 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTPN11      | 5 | E | A | G | protein       | N     | Noonan syndrome       |
| 8 |             | 7 | N | D | o | tyrosine      | CGC,P |                       |
| 6 |             | 8 | S |   | F | phosphatase   | ANEL_ |                       |
|   |             | 1 | G |   |   | non-receptor  | APP,T |                       |
|   |             |   | 0 |   |   | type 11       | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTPN12      | 5 | E | N | N | protein       | PANE  | NA                    |
| 8 |             | 7 | N | A | A | tyrosine      | L_APP |                       |
| 7 |             | 8 | S |   |   | phosphatase   |       |                       |
|   |             | 2 | G |   |   | non-receptor  |       |                       |
|   |             |   | 0 |   |   | type 12       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTPN13      | 5 | E | A | N | protein       | C     | NA                    |
| 8 |             | 7 | N | R | A | tyrosine      | GC_94 |                       |
| 8 |             | 8 | S |   |   | phosphatase   |       |                       |
|   |             | 3 | G |   |   | non-receptor  |       |                       |
|   |             |   | 0 |   |   | type 13       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | PTPRJ       | 5 | E | N | N | protein       | OTHER | NA                    |
| 8 |             | 7 | N | A | A | tyrosine      |       |                       |
| 9 |             | 9 | S |   |   | phosphatase   |       |                       |
|   |             | 5 | G |   |   | receptor type |       |                       |
|   |             |   | 0 |   |   | J             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RABL3       | 2 | E | A | N | RAB, member   | PANE  | NA                    |
| 9 |             | 8 | N | D | A | of RAS        | L_APP |                       |
| 0 |             | 5 | S |   |   | oncogene      |       |                       |
|   |             | 2 | G |   |   | family like 3 |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD50       | 1 | E | A | L | RAD50 double  | NCGC  | NA                    |
| 9 |             | 0 | N | D | o | strand break  |       |                       |
| 1 |             | 1 | S | / | F | repair        |       |                       |
|   |             | 1 | G | A |   | protein       |       |                       |
|   |             | 1 | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD51       | 5 | E | A | N | RAD51         | NCGC  | NA                    |
| 9 |             | 8 | N | D | A | recombinase   | ,PANE |                       |
| 2 |             | 8 | S |   |   |               | L_APP |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD51B      | 5 | E | N | N | RAD51 paralog | NCGC  | NA                    |
| 9 |             | 8 | N | A | A | B             |       |                       |
| 3 |             | 9 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD51C      | 5 | E | A | L | RAD51 paralog | N     | Fanconi anemia,       |
| 9 |             | 8 | N | D | o | C             | CGC,P | complementation group |
| 4 |             | 8 | S | / | F |               | ANEL_ | O                     |
|   |             | 9 | G | A |   |               | APP,T |                       |
|   |             |   | 0 | R |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD51D      | 5 | E | A | L | RAD51 paralog | N     | Breast-ovarian        |
| 9 |             | 8 | N | D | o | D             | CGC,P | cancer, familial 4    |
| 5 |             | 9 | S |   | F |               | ANEL_ |                       |
|   |             | 2 | G |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAD54L      | 8 | E | N | N | RAD54 like    | PANE  | NA                    |
| 9 |             | 4 | N | A | A |               | L_APP |                       |
| 6 |             | 3 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RAF1        | 5 | E | A | N | Raf-1         | P     | LEOPARD syndrome 2;   |
| 9 |             | 8 | N | D | A | pr            | ANEL_ | Noonan syndrome 5     |
| 7 |             | 9 | S |   |   | oto-oncogene, | APP,T |                       |
|   |             | 4 | G |   |   | ser           | CGA_P |                       |
|   |             |   | 0 |   |   | ine/threonine | ANCAN |                       |
|   |             |   | 0 |   |   | kinase        | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RASA1       | 5 | E | N | N | RAS p21       | OTHER | NA                    |
| 9 |             | 9 | N | A | A | protein       |       |                       |
| 8 |             | 2 | S |   |   | activator 1   |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 2 | RB1         | 5 | E | A | L | RB            | ACM   | Osteosarcoma;         |
| 9 |             | 9 | N | D | o | tr            | G_SF3 | Retinoblastoma        |
| 9 |             | 2 | S | / | F | anscriptional | 0,CGC |                       |
|   |             | 5 | G | A |   | corepressor 1 | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RCC2        | 5 | E | N | N | regulator of  | NCGC  | NA                    |
| 0 |             | 5 | N | A | A | chromosome    |       |                       |
| 0 |             | 9 | S |   |   | condensation  |       |                       |
|   |             | 2 | G |   |   | 2             |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RECQL       | 5 | E | A | N | RecQ like     | T     | NA                    |
| 0 |             | 9 | N | D | A | helicase      | CGA_P |                       |
| 1 |             | 6 | S |   |   |               | ANCAN |                       |
|   |             | 5 | G |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RECQL4      | 9 | E | A | L | RecQ like     | CGC   | Rothmund-Thomson      |
| 0 |             | 4 | N | R | o | helicase 4    | _94,N | syndrome              |
| 2 |             | 0 | S |   | F |               | CGC,P |                       |
|   |             | 1 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | REST        | 5 | E | A | N | RE1 silencing | PANE  | NA                    |
| 0 |             | 9 | N | D | A | transcription | L_APP |                       |
| 3 |             | 7 | S |   |   | factor        |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RET         | 5 | E | A | G | ret           | ACM   | Multiple endocrine    |
| 0 |             | 9 | N | D | o | p             | G_SF3 | neoplasia, type 2a;   |
| 4 |             | 7 | S |   | F | roto-oncogene | 0,CGC | Multiple endocrine    |
|   |             | 9 | G |   |   |               | _94,N | neoplasia, type 2b;   |
|   |             |   | 0 |   |   |               | CGC,P | Familial medullary    |
|   |             |   | 0 |   |   |               | ANEL_ | thyroid carcinoma     |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RFWD3       | 5 | E | N | N | ring finger   | C     | NA                    |
| 0 |             | 5 | N | A | A | and WD repeat | GC_94 |                       |
| 5 |             | 1 | S |   |   | domain 3      |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RHBDF2      | 7 | E | A | G | rhomboid 5    | N     | Palmoplantar          |
| 0 |             | 9 | N | D | o | homolog 2     | CGC,T | k                     |
| 6 |             | 6 | S |   | F |               | CGA_P | eratoderma-esophageal |
|   |             | 5 | G |   |   |               | ANCAN | carcinoma syndrome    |
|   |             | 1 | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RING1       | 6 | E | N | N | ring finger   | NCGC  | NA                    |
| 0 |             | 0 | N | A | A | protein 1     |       |                       |
| 7 |             | 1 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RINT1       | 6 | E | N | N | RAD50         | NCGC  | NA                    |
| 0 |             | 0 | N | A | A | interactor 1  |       |                       |
| 8 |             | 5 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RIT1        | 6 | E | A | N | Ras like      | PANE  | NA                    |
| 0 |             | 0 | N | D | A | without CAAX  | L_APP |                       |
| 9 |             | 1 | S |   |   | 1             |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RMRP        | 6 | E | A | L | RNA component | P     | Metaphyseal           |
| 1 |             | 0 | N | R | o | of            | ANEL_ | chondrodysplasia,     |
| 0 |             | 2 | S |   | F | mitochondrial | APP,T | McKusick type         |
|   |             | 3 | G |   |   | RNA           | CGA_P |                       |
|   |             |   | 0 |   |   | processing    | ANCAN |                       |
|   |             |   | 0 |   |   | end           | _2018 |                       |
|   |             |   | 0 |   |   | oribonuclease |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RNASEL      | 6 | E | N | N | ribonuclease  | PANE  | NA                    |
| 1 |             | 0 | N | A | A | L             | L_APP |                       |
| 1 |             | 4 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RNF43       | 5 | E | A | N | ring finger   | PANE  | NA                    |
| 1 |             | 4 | N | D | A | protein 43    | L_APP |                       |
| 2 |             | 8 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | ROS1        | 6 | E | N | N | ROS           | OTHER | NA                    |
| 1 |             | 0 | N | A | A | p             |       |                       |
| 3 |             | 9 | S |   |   | roto-oncogene |       |                       |
|   |             | 8 | G |   |   | 1, receptor   |       |                       |
|   |             |   | 0 |   |   | tyrosine      |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL11       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 1 | N | D | A | protein L11   | L_APP |                       |
| 4 |             | 3 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL15       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 1 | N | D | A | protein L15   | L_APP |                       |
| 5 |             | 3 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL23       | 9 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 3 | N | D | A | protein L23   | L_APP |                       |
| 6 |             | 4 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL26       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 1 | N | D | A | protein L26   | L_APP |                       |
| 7 |             | 5 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL27       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 1 | N | D | A | protein L27   | L_APP |                       |
| 8 |             | 5 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL31       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 1 |             | 1 | N | D | A | protein L31   | L_APP |                       |
| 9 |             | 6 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL35A      | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 1 | N | D | A | protein L35a  | L_APP |                       |
| 0 |             | 6 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL36       | 2 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 5 | N | D | A | protein L36   | L_APP |                       |
| 1 |             | 8 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPL5        | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 1 | N | D | A | protein L5    | L_APP |                       |
| 2 |             | 2 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS10       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S10   | L_APP |                       |
| 3 |             | 0 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS15       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S15   | L_APP |                       |
| 4 |             | 0 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS17       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S17   | L_APP |                       |
| 5 |             | 1 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS19       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S19   | L_APP |                       |
| 6 |             | 2 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS24       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S24   | L_APP |                       |
| 7 |             | 2 | S |   |   |               |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS26       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S26   | L_APP |                       |
| 8 |             | 3 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS27       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 2 |             | 2 | N | D | A | protein S27   | L_APP |                       |
| 9 |             | 3 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS27A      | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 3 |             | 2 | N | D | A | protein S27a  | L_APP |                       |
| 0 |             | 3 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS28       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 3 |             | 2 | N | D | A | protein S28   | L_APP |                       |
| 1 |             | 3 | S |   |   |               |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS29       | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 3 |             | 2 | N | D | A | protein S29   | L_APP |                       |
| 2 |             | 3 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RPS7        | 6 | E | A | N | ribosomal     | PANE  | NA                    |
| 3 |             | 2 | N | D | A | protein S7    | L_APP |                       |
| 3 |             | 0 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RRAS2       | 2 | E | N | N | RAS related 2 | PANE  | NA                    |
| 3 |             | 2 | N | A | A |               | L_APP |                       |
| 4 |             | 8 | S |   |   |               |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RTEL1       | 5 | E | A | N | regulator of  | PANE  | NA                    |
| 3 |             | 1 | N | D | A | telomere      | L_APP |                       |
| 5 |             | 7 | S | / |   | elongation    |       |                       |
|   |             | 5 | G | A |   | helicase 1    |       |                       |
|   |             | 0 | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | RUNX1       | 8 | N | A | L | RUNX family   | N     | Familial platelet     |
| 3 |             | 6 | A | D | o | transcription | CGC,P | disorder with         |
| 6 |             | 1 |   |   | F | factor 1      | ANEL_ | associated myeloid    |
|   |             |   |   |   |   |               | APP,T | malignancy            |
|   |             |   |   |   |   |               | CGA_P |                       |
|   |             |   |   |   |   |               | ANCAN |                       |
|   |             |   |   |   |   |               | _2018 |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SAMD9       | 5 | E | A | N | sterile alpha | PANE  | NA                    |
| 3 |             | 4 | N | D | A | motif domain  | L_APP |                       |
| 7 |             | 8 | S | / |   | containing 9  |       |                       |
|   |             | 0 | G | A |   |               |       |                       |
|   |             | 9 | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SAMD9L      | 2 | E | A | N | sterile alpha | PANE  | NA                    |
| 3 |             | 1 | N | D | A | motif domain  | L_APP |                       |
| 8 |             | 9 | S |   |   | containing 9  |       |                       |
|   |             | 2 | G |   |   | like          |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SASH1       | 2 | E | A | N | SAM and SH3   | PANE  | NA                    |
| 3 |             | 3 | N | D | A | domain        | L_APP |                       |
| 9 |             | 3 | S | / |   | containing 1  |       |                       |
|   |             | 2 | G | A |   |               |       |                       |
|   |             | 8 | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SBDS        | 5 | E | A | L | SBDS ribosome | CGC   | Shwachman syndrome    |
| 4 |             | 1 | N | R | o | maturation    | _94,N |                       |
| 0 |             | 1 | S |   | F | factor        | CGC,P |                       |
|   |             | 1 | G |   |   |               | ANEL_ |                       |
|   |             | 9 | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SCG5        | 6 | E | N | N | secretogranin | NCGC  | NA                    |
| 4 |             | 4 | N | A | A | V             |       |                       |
| 1 |             | 4 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SDHA        | 6 | E | A | L | succinate     | CGC   | Paragangliomas 5      |
| 4 |             | 3 | N | D | o | dehydrogenase | _94,N |                       |
| 2 |             | 8 | S | / | F | complex       | CGC,P |                       |
|   |             | 9 | G | A |   | flavoprotein  | ANEL_ |                       |
|   |             |   | 0 | R |   | subunit A     | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SDHAF2      | 5 | E | A | L | succinate     | ACM   | Hereditary            |
| 4 |             | 4 | N | D | o | dehydrogenase | G_SF3 | Paragangl             |
| 3 |             | 9 | S | / | F | complex       | 0,CGC | ioma-Pheochromocytoma |
|   |             | 4 | G | A |   | assembly      | _94,N | Syndromes             |
|   |             | 9 | 0 | R |   | factor 2      | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SDHB        | 6 | E | A | L | succinate     | ACM   | Hereditary            |
| 4 |             | 3 | N | D | o | dehydrogenase | G_SF3 | Paragangl             |
| 4 |             | 9 | S | / | F | complex iron  | 0,CGC | ioma-Pheochromocytoma |
|   |             | 0 | G | A |   | sulfur        | _94,N | Syndromes;            |
|   |             |   | 0 | R |   | subunit B     | CGC,P | Carney-Stratakis      |
|   |             |   | 0 |   |   |               | ANEL_ | syndrome              |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SDHC        | 6 | E | A | L | succinate     | ACM   | Hereditary            |
| 4 |             | 3 | N | D | o | dehydrogenase | G_SF3 | Paragangl             |
| 5 |             | 9 | S | / | F | complex       | 0,CGC | ioma-Pheochromocytoma |
|   |             | 1 | G | A |   | subunit C     | _94,N | Syndromes;            |
|   |             |   | 0 | R |   |               | CGC,P | Carney-Stratakis      |
|   |             |   | 0 |   |   |               | ANEL_ | syndrome              |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SDHD        | 6 | E | A | L | succinate     | ACM   | Hereditary            |
| 4 |             | 3 | N | D | o | dehydrogenase | G_SF3 | Paragangl             |
| 6 |             | 9 | S | / | F | complex       | 0,CGC | ioma-Pheochromocytoma |
|   |             | 2 | G | A |   | subunit D     | _94,N | Syndromes;            |
|   |             |   | 0 | R |   |               | CGC,P | Carney-Stratakis      |
|   |             |   | 0 |   |   |               | ANEL_ | syndrome              |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 2 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SEC23B      | 1 | E | A | N | SEC23 homolog | PANE  | NA                    |
| 4 |             | 0 | N | D | A | B, COPII coat | L_APP |                       |
| 7 |             | 4 | S |   |   | complex       |       |                       |
|   |             | 8 | G |   |   | component     |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SEMA4A      | 6 | E | N | N | semaphorin 4A | OTHER | NA                    |
| 4 |             | 4 | N | A | A |               |       |                       |
| 8 |             | 2 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SERPINA1    | 5 | E | A | L | serpin family | OT    | Alpha-1-antitrypsin   |
| 4 |             | 2 | N | R | o | A member 1    | HER,T | deficiency            |
| 9 |             | 6 | S |   | F |               | CGA_P |                       |
|   |             | 5 | G |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SETBP1      | 2 | E | A | N | SET binding   | CGC   | Schinzel-Giedion      |
| 5 |             | 6 | N | D | A | protein 1     | _94,T | syndrome              |
| 0 |             | 0 | S |   |   |               | CGA_P |                       |
|   |             | 4 | G |   |   |               | ANCAN |                       |
|   |             | 0 | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SETMAR      | 6 | E | N | N | SET domain    | OTHER | NA                    |
| 5 |             | 4 | N | A | A | and mariner   |       |                       |
| 1 |             | 1 | S |   |   | transposase   |       |                       |
|   |             | 9 | G |   |   | fusion gene   |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SFTPA1      | 6 | E | N | N | surfactant    | OTHER | NA                    |
| 5 |             | 5 | N | A | A | protein A1    |       |                       |
| 2 |             | 3 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SFTPA2      | 7 | E | N | N | surfactant    | OTHER | NA                    |
| 5 |             | 2 | N | A | A | protein A2    |       |                       |
| 3 |             | 9 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SH2B3       | 1 | E | A | N | SH2B adaptor  | P     | NA                    |
| 5 |             | 0 | N | R | A | protein 3     | ANEL_ |                       |
| 4 |             | 0 | S |   |   |               | APP,T |                       |
|   |             | 1 | G |   |   |               | CGA_P |                       |
|   |             | 9 | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SH2D1A      | 4 | E | N | L | SH2 domain    | P     | NA                    |
| 5 |             | 0 | N | A | o | containing 1A | ANEL_ |                       |
| 5 |             | 6 | S |   | F |               | APP,T |                       |
|   |             | 8 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SHOC2       | 8 | E | A | N | SHOC2 leucine | P     | Noonan syndrome-like  |
| 5 |             | 0 | N | D | A | rich repeat   | ANEL_ | disorder with loose   |
| 6 |             | 3 | S |   |   | scaffold      | APP,T | anagen hair           |
|   |             | 6 | G |   |   | protein       | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SIX1        | 6 | E | N | N | SIX homeobox  | OTHER | NA                    |
| 5 |             | 4 | N | A | A | 1             |       |                       |
| 7 |             | 9 | S |   |   |               |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SLC25A13    | 1 | E | A | L | solute        | T     | NA                    |
| 5 |             | 0 | N | R | o | carrier       | CGA_P |                       |
| 8 |             | 1 | S |   | F | family 25     | ANCAN |                       |
|   |             | 6 | G |   |   | member 13     | _2018 |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SLC26A3     | 1 | E | N | N | solute        | PANE  | NA                    |
| 5 |             | 8 | N | A | A | carrier       | L_APP |                       |
| 9 |             | 1 | S |   |   | family 26     |       |                       |
|   |             | 1 | G |   |   | member 3      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SLC5A5      | 6 | E | A | N | solute        | PANE  | NA                    |
| 6 |             | 5 | N | R | A | carrier       | L_APP |                       |
| 0 |             | 2 | S |   |   | family 5      |       |                       |
|   |             | 8 | G |   |   | member 5      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SLX4        | 8 | E | A | L | SLX4          | NCGC  | NA                    |
| 6 |             | 4 | N | R | o | struc         | ,PANE |                       |
| 1 |             | 4 | S |   | F | ture-specific | L_APP |                       |
|   |             | 6 | G |   |   | endonuclease  |       |                       |
|   |             | 4 | 0 |   |   | subunit       |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMAD4       | 4 | E | A | L | SMAD family   | ACM   | Hereditary            |
| 6 |             | 0 | N | D | o | member 4      | G_SF3 | hemorrhagic           |
| 2 |             | 8 | S | / | F |               | 0,CGC | telangiectasia;       |
|   |             | 9 | G | A |   |               | _94,N | Juvenile polyposis    |
|   |             |   | 0 | R |   |               | CGC,P | syndrome              |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMAD9       | 4 | E | A | N | SMAD family   | PANE  | NA                    |
| 6 |             | 0 | N | D | A | member 9      | L_APP |                       |
| 3 |             | 9 | S |   |   |               |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMARCA2     | 6 | E | A | N | SWI/SNF       | OTHER | NA                    |
| 6 |             | 5 | N | R | A | related,      |       |                       |
| 4 |             | 9 | S |   |   | matrix        |       |                       |
|   |             | 5 | G |   |   | associated,   |       |                       |
|   |             |   | 0 |   |   | actin         |       |                       |
|   |             |   | 0 |   |   | dependent     |       |                       |
|   |             |   | 0 |   |   | regulator of  |       |                       |
|   |             |   | 0 |   |   | chromatin,    |       |                       |
|   |             |   | 0 |   |   | subfamily a,  |       |                       |
|   |             |   | 0 |   |   | member 2      |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMARCA4     | 6 | E | A | L | SWI/SNF       | N     | Rhabdoid tumor        |
| 6 |             | 5 | N | D | o | related,      | CGC,P | predisposition        |
| 5 |             | 9 | S | / | F | matrix        | ANEL_ | syndrome 2            |
|   |             | 7 | G | A |   | associated,   | APP,T |                       |
|   |             |   | 0 | R |   | actin         | CGA_P |                       |
|   |             |   | 0 |   |   | dependent     | ANCAN |                       |
|   |             |   | 0 |   |   | regulator of  | _2018 |                       |
|   |             |   | 0 |   |   | chromatin,    |       |                       |
|   |             |   | 0 |   |   | subfamily a,  |       |                       |
|   |             |   | 1 |   |   | member 4      |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMARCB1     | 6 | E | A | L | SWI/SNF       | CGC   | Rhabdoid tumor        |
| 6 |             | 5 | N | D | o | related,      | _94,N | predisposition        |
| 6 |             | 9 | S | / | F | matrix        | CGC,P | syndrome 1            |
|   |             | 8 | G | A |   | associated,   | ANEL_ |                       |
|   |             |   | 0 | R |   | actin         | APP,T |                       |
|   |             |   | 0 |   |   | dependent     | CGA_P |                       |
|   |             |   | 0 |   |   | regulator of  | ANCAN |                       |
|   |             |   | 0 |   |   | chromatin,    | _2018 |                       |
|   |             |   | 0 |   |   | subfamily b,  |       |                       |
|   |             |   | 0 |   |   | member 1      |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMARCE1     | 6 | E | A | L | SWI/SNF       | CGC   | Hereditary Meningioma |
| 6 |             | 6 | N | D | o | related,      | _94,N |                       |
| 7 |             | 0 | S | / | F | matrix        | CGC,P |                       |
|   |             | 5 | G | A |   | associated,   | ANEL_ |                       |
|   |             |   | 0 | R |   | actin         | APP,T |                       |
|   |             |   | 0 |   |   | dependent     | CGA_P |                       |
|   |             |   | 0 |   |   | regulator of  | ANCAN |                       |
|   |             |   | 0 |   |   | chromatin,    | _2018 |                       |
|   |             |   | 0 |   |   | subfamily e,  |       |                       |
|   |             |   | 0 |   |   | member 1      |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SMO         | 6 | E | N | N | smoothened,   | OTHER | NA                    |
| 6 |             | 6 | N | A | A | frizzled      |       |                       |
| 8 |             | 0 | S |   |   | class         |       |                       |
|   |             | 8 | G |   |   | receptor      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SOCS1       | 8 | E | N | N | suppressor of | OTHER | NA                    |
| 6 |             | 6 | N | A | A | cytokine      |       |                       |
| 9 |             | 5 | S |   |   | signaling 1   |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SOS1        | 6 | E | A | G | SOS Ras/Rac   | P     | Noonan syndrome       |
| 7 |             | 6 | N | D | o | guanine       | ANEL_ |                       |
| 0 |             | 5 | S |   | F | nucleotide    | APP,T |                       |
|   |             | 4 | G |   |   | exchange      | CGA_P |                       |
|   |             |   | 0 |   |   | factor 1      | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SOS2        | 6 | E | A | N | SOS Ras/Rho   | PANE  | NA                    |
| 7 |             | 6 | N | D | A | guanine       | L_APP |                       |
| 1 |             | 5 | S |   |   | nucleotide    |       |                       |
|   |             | 5 | G |   |   | exchange      |       |                       |
|   |             |   | 0 |   |   | factor 2      |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SPINK1      | 6 | E | N | N | serine        | NCGC  | NA                    |
| 7 |             | 6 | N | A | A | peptidase     |       |                       |
| 2 |             | 9 | S |   |   | inhibitor     |       |                       |
|   |             | 0 | G |   |   | Kazal type 1  |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SPOP        | 8 | E | A | N | speckle type  | C     | NA                    |
| 7 |             | 4 | N | R | A | BTB/POZ       | GC_94 |                       |
| 3 |             | 0 | S |   |   | protein       | ,PANE |                       |
|   |             | 5 | G |   |   |               | L_APP |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SPRED1      | 1 | E | A | N | sprouty       | NCGC  | NA                    |
| 7 |             | 6 | N | D | A | related EVH1  | ,PANE |                       |
| 4 |             | 1 | S |   |   | domain        | L_APP |                       |
|   |             | 7 | G |   |   | containing 1  |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SPRTN       | 8 | E | A | N | SprT-like     | T     | Ruijs-Aalfs syndrome  |
| 7 |             | 3 | N | R | A | N-terminal    | CGA_P |                       |
| 5 |             | 9 | S |   |   | domain        | ANCAN |                       |
|   |             | 3 | G |   |   |               | _2018 |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SQSTM1      | 8 | E | A | N | sequestosome  | PANE  | NA                    |
| 7 |             | 8 | N | D | A | 1             | L_APP |                       |
| 6 |             | 7 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SRC         | 6 | E | N | N | SRC           | PANE  | NA                    |
| 7 |             | 7 | N | A | A | pr            | L_APP |                       |
| 7 |             | 1 | S |   |   | oto-oncogene, |       |                       |
|   |             | 4 | G |   |   | non-receptor  |       |                       |
|   |             |   | 0 |   |   | tyrosine      |       |                       |
|   |             |   | 0 |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SRGAP1      | 5 | E | A | N | SLIT-ROBO Rho | PANE  | NA                    |
| 7 |             | 7 | N | D | A | GTPase        | L_APP |                       |
| 8 |             | 5 | S |   |   | activating    |       |                       |
|   |             | 2 | G |   |   | protein 1     |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SRP72       | 6 | E | A | N | signal        | PANE  | NA                    |
| 7 |             | 7 | N | D | A | recognition   | L_APP |                       |
| 9 |             | 3 | S |   |   | particle 72   |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SRRM2       | 2 | E | A | N | se            | PANE  | NA                    |
| 8 |             | 3 | N | D | A | rine/arginine | L_APP |                       |
| 0 |             | 5 | S |   |   | repetitive    |       |                       |
|   |             | 2 | G |   |   | matrix 2      |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SRY         | 6 | E | N | N | sex           | T     | Gonadoblastoma        |
| 8 |             | 7 | N | A | A | determining   | CGA_P |                       |
| 1 |             | 3 | S |   |   | region Y      | ANCAN |                       |
|   |             | 6 | G |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | STAT3       | 6 | E | A | L | signal        | CGC   | STAT3 Deficiency      |
| 8 |             | 7 | N | D | o | transducer    | _94,P |                       |
| 2 |             | 7 | S |   | F | and activator | ANEL_ |                       |
|   |             | 4 | G |   |   | of            | APP,T |                       |
|   |             |   | 0 |   |   | transcription | CGA_P |                       |
|   |             |   | 0 |   |   | 3             | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | STK11       | 6 | E | A | L | ser           | ACM   | Peutz-Jeghers         |
| 8 |             | 7 | N | D | o | ine/threonine | G_SF3 | syndrome              |
| 3 |             | 9 | S | / | F | kinase 11     | 0,CGC |                       |
|   |             | 4 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | STN1        | 7 | E | A | N | STN1 subunit  | PANE  | NA                    |
| 8 |             | 9 | N | D | A | of CST        | L_APP |                       |
| 4 |             | 9 | S |   |   | complex       |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | STX11       | 8 | E | A | N | syntaxin 11   | PANE  | NA                    |
| 8 |             | 6 | N | R | A |               | L_APP |                       |
| 5 |             | 7 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | STXBP2      | 6 | E | A | N | syntaxin      | PANE  | NA                    |
| 8 |             | 8 | N | R | A | binding       | L_APP |                       |
| 6 |             | 1 | S |   |   | protein 2     |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SUFU        | 5 | E | A | L | SUFU negative | CGC   | Medulloblastoma;      |
| 8 |             | 1 | N | D | o | regulator of  | _94,N | Hereditary Meningioma |
| 7 |             | 6 | S | / | F | hedgehog      | CGC,P |                       |
|   |             | 8 | G | A |   | signaling     | ANEL_ |                       |
|   |             | 4 | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | SYK         | 6 | E | N | N | spleen        | OTHER | NA                    |
| 8 |             | 8 | N | A | A | associated    |       |                       |
| 8 |             | 5 | S |   |   | tyrosine      |       |                       |
|   |             | 0 | G |   |   | kinase        |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TBXT        | 6 | E | A | N | T-box         | PANE  | NA                    |
| 8 |             | 8 | N | D | A | transcription | L_APP |                       |
| 9 |             | 6 | S |   |   | factor T      |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TCF7L2      | 6 | E | N | N | transcription | OTHER | NA                    |
| 9 |             | 9 | N | A | A | factor 7 like |       |                       |
| 0 |             | 3 | S |   |   | 2             |       |                       |
|   |             | 4 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TERC        | 7 | E | A | N | telomerase    | PANE  | NA                    |
| 9 |             | 0 | N | D | A | RNA component | L_APP |                       |
| 1 |             | 1 | S |   |   |               |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TERF2IP     | 5 | N | N | N | TERF2         | NCGC  | NA                    |
| 9 |             | 4 | A | A | A | interacting   | ,PANE |                       |
| 2 |             | 3 |   |   |   | protein       | L_APP |                       |
|   |             | 8 |   |   |   |               |       |                       |
|   |             | 6 |   |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TERT        | 7 | E | A | L | telomerase    | CGC   | Autosomal dominant    |
| 9 |             | 0 | N | D | o | reverse       | _94,N | dyskeratosis          |
| 3 |             | 1 | S | / | F | transcriptase | CGC,P | congenita             |
|   |             | 5 | G | A |   |               | ANEL_ |                       |
|   |             |   | 0 | R |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TET2        | 5 | E | N | N | tet           | OTHER | NA                    |
| 9 |             | 4 | N | A | A | m             |       |                       |
| 4 |             | 7 | S |   |   | ethylcytosine |       |                       |
|   |             | 9 | G |   |   | dioxygenase 2 |       |                       |
|   |             | 0 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TFAP2A      | 7 | E | A | N | transcription | OTHER | NA                    |
| 9 |             | 0 | N | D | A | factor AP-2   |       |                       |
| 5 |             | 2 | S |   |   | alpha         |       |                       |
|   |             | 0 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TFE3        | 7 | E | N | N | transcription | OTHER | NA                    |
| 9 |             | 0 | N | A | A | factor        |       |                       |
| 6 |             | 3 | S |   |   | binding to    |       |                       |
|   |             | 0 | G |   |   | IGHM enhancer |       |                       |
|   |             |   | 0 |   |   | 3             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TG          | 7 | E | A | N | thyroglobulin | PANE  | NA                    |
| 9 |             | 0 | N | R | A |               | L_APP |                       |
| 7 |             | 3 | S |   |   |               |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TGFBR1      | 7 | E | A | L | transforming  | A     | Multiple self-healing |
| 9 |             | 0 | N | D | o | growth factor | CMG_S | squamous epithelioma; |
| 8 |             | 4 | S |   | F | beta receptor | F30,T | Loeys-Dietz syndrome  |
|   |             | 6 | G |   |   | 1             | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 3 | TGFBR2      | 7 | E | A | L | transforming  | A     | Loeys-Dietz syndrome  |
| 9 |             | 0 | N | R | o | growth factor | CMG_S |                       |
| 9 |             | 4 | S |   | F | beta receptor | F30,C |                       |
|   |             | 8 | G |   |   | 2             | GC_94 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TINF2       | 2 | E | A | N | TERF1         | PANE  | NA                    |
| 0 |             | 6 | N | D | A | interacting   | L_APP |                       |
| 0 |             | 2 | S |   |   | nuclear       |       |                       |
|   |             | 7 | G |   |   | factor 2      |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TMC6        | 1 | E | A | N | transmembrane | PANE  | NA                    |
| 0 |             | 1 | N | R | A | channel like  | L_APP |                       |
| 1 |             | 3 | S |   |   | 6             |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TMC8        | 1 | E | A | N | transmembrane | PANE  | NA                    |
| 0 |             | 4 | N | R | A | channel like  | L_APP |                       |
| 2 |             | 7 | S |   |   | 8             |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             | 3 | 0 |   |   |               |       |                       |
|   |             | 8 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TMEM127     | 5 | E | A | L | transmembrane | ACM   | Pheochromocytoma;     |
| 0 |             | 5 | N | D | o | protein 127   | G_SF3 | Hereditary            |
| 3 |             | 6 | S | / | F |               | 0,CGC | Paragangl             |
|   |             | 5 | G | A |   |               | _94,N | ioma-Pheochromocytoma |
|   |             | 4 | 0 | R |   |               | CGC,P | Syndromes             |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TNFAIP3     | 7 | E | N | N | TNF alpha     | OTHER | NA                    |
| 0 |             | 1 | N | A | A | induced       |       |                       |
| 4 |             | 2 | S |   |   | protein 3     |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TNFRSF11A   | 8 | E | A | N | TNF receptor  | PANE  | NA                    |
| 0 |             | 7 | N | D | A | superfamily   | L_APP |                       |
| 5 |             | 9 | S |   |   | member 11a    |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TP53        | 7 | E | A | L | tumor protein | ACM   | NA; Li-Fraumeni       |
| 0 |             | 1 | N | D | o | p53           | G_SF3 | syndrome 1            |
| 6 |             | 5 | S | / | F |               | 0,CGC |                       |
|   |             | 7 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TP63        | 8 | E | N | N | tumor protein | C     | NA                    |
| 0 |             | 6 | N | A | A | p63           | GC_94 |                       |
| 7 |             | 2 | S |   |   |               |       |                       |
|   |             | 6 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TRIM24      | 8 | E | N | N | tripartite    | OTHER | NA                    |
| 0 |             | 8 | N | A | A | motif         |       |                       |
| 8 |             | 0 | S |   |   | containing 24 |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TRIM28      | 1 | E | A | N | tripartite    | PANE  | NA                    |
| 0 |             | 0 | N | D | A | motif         | L_APP |                       |
| 9 |             | 1 | S |   |   | containing 28 |       |                       |
|   |             | 5 | G |   |   |               |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TRIM37      | 4 | E | A | L | tripartite    | P     | NA                    |
| 1 |             | 5 | N | R | o | motif         | ANEL_ |                       |
| 0 |             | 9 | S |   | F | containing 37 | APP,T |                       |
|   |             | 1 | G |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TRIP13      | 9 | E | A | N | thyroid       | PANE  | NA                    |
| 1 |             | 3 | N | R | A | hormone       | L_APP |                       |
| 1 |             | 1 | S |   |   | receptor      |       |                       |
|   |             | 9 | G |   |   | interactor 13 |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TSC1        | 7 | E | A | L | TSC complex   | ACM   | Tuberous sclerosis    |
| 1 |             | 2 | N | D | o | subunit 1     | G_SF3 | syndrome; Tuberous    |
| 2 |             | 4 | S | / | F |               | 0,CGC | sclerosis 1           |
|   |             | 8 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TSC2        | 7 | E | A | L | TSC complex   | ACM   | Tuberous sclerosis    |
| 1 |             | 2 | N | D | o | subunit 2     | G_SF3 | syndrome; Tuberous    |
| 3 |             | 4 | S | / | F |               | 0,CGC | sclerosis 2           |
|   |             | 9 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TSHR        | 7 | E | A | N | thyroid       | CGC   | Hyperthyroidism,      |
| 1 |             | 2 | N | D | A | stimulating   | _94,T | nonautoimmune         |
| 4 |             | 5 | S |   |   | hormone       | CGA_P |                       |
|   |             | 3 | G |   |   | receptor      | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TSR2        | 9 | E | N | N | TSR2 ribosome | PANE  | NA                    |
| 1 |             | 0 | N | A | A | maturation    | L_APP |                       |
| 5 |             | 1 | S |   |   | factor        |       |                       |
|   |             | 2 | G |   |   |               |       |                       |
|   |             | 1 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | TYK2        | 7 | E | A | N | tyrosine      | OTHER | NA                    |
| 1 |             | 2 | N | R | A | kinase 2      |       |                       |
| 6 |             | 9 | S |   |   |               |       |                       |
|   |             | 7 | G |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | UBE2T       | 2 | E | A | N | ubiquitin     | PANE  | NA                    |
| 1 |             | 9 | N | R | A | conjugating   | L_APP |                       |
| 7 |             | 0 | S |   |   | enzyme E2 T   |       |                       |
|   |             | 8 | G |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | UNC13D      | 2 | E | A | N | unc-13        | PANE  | NA                    |
| 1 |             | 0 | N | D | A | homolog D     | L_APP |                       |
| 8 |             | 1 | S | / |   |               |       |                       |
|   |             | 2 | G | A |   |               |       |                       |
|   |             | 9 | 0 | R |   |               |       |                       |
|   |             | 4 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | UROD        | 7 | E | A | L | uro           | T     | Familial porphyria    |
| 1 |             | 3 | N | D | o | porphyrinogen | CGA_P | cutanea tarda         |
| 9 |             | 8 | S | / | F | decarboxylase | ANCAN |                       |
|   |             | 9 | G | A |   |               | _2018 |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | VANGL1      | 8 | E | N | N | VANGL planar  | OTHER | NA                    |
| 2 |             | 1 | N | A | A | cell polarity |       |                       |
| 0 |             | 8 | S |   |   | protein 1     |       |                       |
|   |             | 3 | G |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | VDR         | 7 | E | A | N | vitamin D     | PANE  | NA                    |
| 2 |             | 4 | N | D | A | receptor      | L_APP |                       |
| 1 |             | 2 | S | / |   |               |       |                       |
|   |             | 1 | G | A |   |               |       |                       |
|   |             |   | 0 | R |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | VHL         | 7 | E | A | L | von           | ACM   | Von Hippel-Lindau     |
| 2 |             | 4 | N | D | o | Hippel-Lindau | G_SF3 | syndrome              |
| 2 |             | 2 | S | / | F | tumor         | 0,CGC |                       |
|   |             | 8 | G | A |   | suppressor    | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | VTRNA2-1    | 1 | E | N | N | vault RNA 2-1 | PANE  | NA                    |
| 2 |             | 0 | N | A | A |               | L_APP |                       |
| 3 |             | 0 | S |   |   |               |       |                       |
|   |             | 1 | G |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 6 | 0 |   |   |               |       |                       |
|   |             | 2 | 0 |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             | 9 | 0 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | WAS         | 7 | E | N | L | WASP actin    | CGC   | Thrombocytopenia 1    |
| 2 |             | 4 | N | A | o | nucleation    | _94,P |                       |
| 4 |             | 5 | S |   | F | promoting     | ANEL_ |                       |
|   |             | 4 | G |   |   | factor        | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | WIF1        | 1 | E | N | N | WNT           | OTHER | NA                    |
| 2 |             | 1 | N | A | A | inhibitory    |       |                       |
| 5 |             | 1 | S |   |   | factor 1      |       |                       |
|   |             | 9 | G |   |   |               |       |                       |
|   |             | 7 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | WRAP53      | 5 | E | A | N | WD repeat     | PANE  | NA                    |
| 2 |             | 5 | N | R | A | containing    | L_APP |                       |
| 6 |             | 1 | S |   |   | antisense to  |       |                       |
|   |             | 3 | G |   |   | TP53          |       |                       |
|   |             | 5 | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | WRN         | 7 | E | A | L | WRN RecQ like | CGC   | Werner syndrome       |
| 2 |             | 4 | N | R | o | helicase      | _94,N |                       |
| 7 |             | 8 | S |   | F |               | CGC,P |                       |
|   |             | 6 | G |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | WT1         | 7 | E | A | L | WT1           | ACM   | Wilms tumor 1         |
| 2 |             | 4 | N | D | o | transcription | G_SF3 |                       |
| 8 |             | 9 | S | / | F | factor        | 0,CGC |                       |
|   |             | 0 | G | A |   |               | _94,N |                       |
|   |             |   | 0 | R |   |               | CGC,P |                       |
|   |             |   | 0 |   |   |               | ANEL_ |                       |
|   |             |   | 0 |   |   |               | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 1 |   |   |               | _2018 |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | XPA         | 7 | E | A | L | XPA, DNA      | CGC   | Xeroderma pigmentosum |
| 2 |             | 5 | N | R | o | damage        | _94,N | group A               |
| 9 |             | 0 | S |   | F | recognition   | CGC,P |                       |
|   |             | 7 | G |   |   | and repair    | ANEL_ |                       |
|   |             |   | 0 |   |   | factor        | APP,T |                       |
|   |             |   | 0 |   |   |               | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 3 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | XPC         | 7 | E | A | L | XPC complex   | CGC   | Xeroderma             |
| 3 |             | 5 | N | R | o | subunit, DNA  | _94,N | pigmentosum, group C  |
| 0 |             | 0 | S |   | F | damage        | CGC,P |                       |
|   |             | 8 | G |   |   | recognition   | ANEL_ |                       |
|   |             |   | 0 |   |   | and repair    | APP,T |                       |
|   |             |   | 0 |   |   | factor        | CGA_P |                       |
|   |             |   | 0 |   |   |               | ANCAN |                       |
|   |             |   | 0 |   |   |               | _2018 |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 7 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | XRCC2       | 7 | E | A | L | X-ray repair  | NCGC  | NA                    |
| 3 |             | 5 | N | R | o | cross         | ,PANE |                       |
| 1 |             | 1 | S |   | F | complementing | L_APP |                       |
|   |             | 6 | G |   |   | 2             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
|   |             |   | 8 |   |   |               |       |                       |
|   |             |   | 4 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | XRCC3       | 7 | E | A | N | X-ray repair  | OTHER | NA                    |
| 3 |             | 5 | N | D | A | cross         |       |                       |
| 2 |             | 1 | S |   |   | complementing |       |                       |
|   |             | 7 | G |   |   | 3             |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
|   |             |   | 2 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 5 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
| 4 | ZBTB16      | 7 | E | N | N | zinc finger   | OTHER | NA                    |
| 3 |             | 7 | N | A | A | and BTB       |       |                       |
| 3 |             | 0 | S |   |   | domain        |       |                       |
|   |             | 4 | G |   |   | containing 16 |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 1 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 9 |   |   |               |       |                       |
|   |             |   | 0 |   |   |               |       |                       |
|   |             |   | 6 |   |   |               |       |                       |
+---+-------------+---+---+---+---+---------------+-------+-----------------------+
